ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TGCB Tego Cyber Inc (PK)

0.0925
-0.0025 (-2.63%)
11 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Tego Cyber Inc (PK) USOTC:TGCB OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0025 -2.63% 0.0925 0.08 0.12 0.09374 0.0925 0.0925 29,700 21:05:09

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

17/01/2024 9:02pm

Edgar (US Regulatory)


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: June 30, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from to.

 

Commission File Number 000-56370

 

TEGO CYBER INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

84-2678167

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

8565 South Eastern Avenue, Suite 150

Las Vegas, Nevada, 89123

(Address of Principal Executive Offices) (Zip Code)

 

(855) 939-0100

(Registrant’s Telephone Number, Including Area Code)

 

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class

Trading Symbol(s)

Name of the principal U.S. market

 

Securities registered pursuant to section 12(g) of the Act:

 

Common Stock, par value $0.001

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No ☒.

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☒.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer 

Non-accelerated Filer

Smaller reporting company

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No ☒.

 

As of January 17, 2024 there were 53,776,616 shares of common stock issued and outstanding, par value $0.001 per share.

 

 

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information included in this Annual Report on Form 10-K and other filings of the Registrant under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as well as information communicated orally or in writing between the dates of such filings, contains or may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements in this Annual Report on Form 10-K, including without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from expected results. Among these risks, trends and uncertainties are the availability of working capital to fund our operations, the competitive market in which we operate, the efficient and uninterrupted operation of our computer and communications systems, our ability to generate a profit and execute our business plan, the retention of key personnel, our ability to protect and defend our intellectual property, the effects of governmental regulation, and other risks identified in the Registrant’s filings with the Securities and Exchange Commission from time to time.

 

In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms or other comparable terminology. Although the Registrant believes that the expectations reflected in the forward-looking statements contained herein are reasonable, the Registrant cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither the Registrant, nor any other person, assumes responsibility for the accuracy and completeness of such statements. The Registrant is under no duty to update any of the forward-looking statements contained herein after the date of this Annual Report on Form 10-K.

 

 

 

 

TEGO CYBER INC.

 

FORM 10-K

JUNE 30, 2023

 

INDEX

 

 

 

 

Page

 

Part I

 

 

 

Item 1.

Business

 

3

 

Item 1A.

Risk Factors

 

8

 

Item 1B.

Unresolved Staff Comments

 

8

 

Item 2.

Properties

 

8

 

Item 3.

Legal Proceedings

 

8

 

Item 4.

Mine Safety Disclosures

 

8

 

 

 

 

 

Part II

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

9

 

Item 6.

[Reserved]

 

14

 

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

14

 

Item 7.A

Quantitative and Qualitative Disclosure About Market Risk

 

18

 

Item 8.

Financial Statements and Supplementary Data

 

18

 

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosures

 

45

 

Item 9.A

Controls and Procedures

 

45

 

Item 9.B

Other Information

 

46

 

Item 9.C

Disclosure Regarding Foreign Jurisdiction that Prevent Inspection

 

46

 

 

 

 

 

Part III

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

 

47

 

Item 11.

Executive Compensation

 

52

 

Item 12. 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

54

 

Item 13.

Certain Relationships and Related Transactions, and Director Independence

 

56

 

Item 14.

Principle Accountant Fees and Services

 

57

 

 

 

 

 

Part IV

 

 

 

Item 15.

Exhibits and Financial Statements

 

58

 

Item 16.

Form 10-K Summary

 

59

 

 

 

 

 

 

Signatures

 

60

 

 

 
2

Table of Contents

 

PART I

 

Item 1. Business

 

The Company Overview

 

Tego Cyber Inc. (the “Company” or “We” or “Our”) is a Nevada based publicly traded cybersecurity company. It was created to mitigate the disparity in the rapidly evolving cyber threat hunting, correlation, and threat intelligence market. The company is focused on developing solutions for threat intelligence and autonomous threat hunting/correlation. Tego’s curated threat intelligence feed not only contains a comprehensive list of indicators of compromise, but also provides additional context including specific details needed to counteract threats so that security teams can spend less time searching for disjointed indicators of compromise. Tego’s threat correlation engine integrates with top security and datalake platforms to proactively identify threats. The Tego threat correlation engine allows security teams to find threats faster using curated data feeds, powerful and low latency searches across large disparate data sets, and user-friendly visualizations that help reduce the time to detection and response.

 

Corporate History and General Information about the Company

 

Tego Cyber Inc. is an early-stage company which was incorporated in the State of Nevada on September 6, 2019. Our year end is June 30. We are a development stage enterprise. We are engaged in the business of the development and commercialization of innovative cybersecurity applications that help enterprises reduce risk, remediate cyber-attacks, and protect intellectual property and data.

 

Our principal office is located at 8565 South Eastern Avenue, Suite 150, Las Vegas, Nevada, 89123. Our telephone number is (855) 939-0100 and our general e-mail contact is info@tegocyber.com. Our website can be viewed at www.tegocyber.com. We have not filed for bankruptcy, receivership or any similar proceedings nor is in the process of filing for bankruptcy, receivership or any similar proceedings.

 

Business and Market Summary

 

The cybersecurity industry has emerged as a critical pillar in the digital age, where organizations and individuals face an ever-growing threat landscape. With the proliferation of technology and the interconnectedness of our world, protecting sensitive information and digital assets has become paramount. Cybersecurity encompasses the practices, processes, and technologies designed to safeguard computer systems, networks, and data from unauthorized access, theft, or damage.

 

In recent years, the cybersecurity landscape has witnessed a dramatic surge in attacks, leaving organizations at an increased risk of compromise. Cybercriminals are constantly refining their tactics, exploiting vulnerabilities in software, networks, and human behavior to gain unauthorized access and wreak havoc. The consequences of successful cyberattacks can be severe, ranging from financial losses and reputational damage to legal implications and the compromise of sensitive customer information.

 

One of the key challenges facing organizations today is the expanded attack surface resulting from the rise of remote work and the proliferation of Internet of Things (IoT) devices. The COVID-19 pandemic accelerated the adoption of remote work models, allowing employees to work from home or other locations outside the traditional office environment. While this provided flexibility and continuity, it also introduced new vulnerabilities and increased the potential for cyberattacks.

 

The cybersecurity industry plays a pivotal role in safeguarding organizations and individuals from the ever-increasing cyber threats. By prioritizing security, staying informed about emerging threats, and fostering collaboration, organizations can better protect themselves and mitigate the risks associated with the expanded attack surface in the digital landscape.

 

 
3

Table of Contents

 

The Industry/Marketplace

 

The market for cybersecurity solutions is highly fragmented, intensely competitive, and constantly evolving. In terms of overall cyberthreats, a Juniper Research report on cybercrime from 2019, suggests that the cost of such malicious attacks will rise to US$5 trillion by 2024. To successfully defend against the malicious attacks they face, it is necessary for the enterprise to adopt cybersecurity awareness, prevention, and security best practices, as a part of their corporate culture, and invest and deploy technology solutions to defend and detect attacks to eliminate the inevitable financial risks presented by daily threats, attacks and breaches.

 

The cybersecurity marketplace is large and rapidly expanding. Projections have this market growing at a Compound Annual Growth Rate (CAGR) of 8% from $173 billion in 2020 to $270 billion by 2026 (Gartner). The cyber threat intelligence segment of the overall cybersecurity market is estimated to be currently valued at $5.3 billion in 2018 and is projected to grow at a CAGR of 19.7% to reach $12.9 billion by 2023, twice the projected growth rate of the overall cybersecurity market.

 

The Company’s Presence in the Market

 

As an emerging provider of ‘intelligent’ threat intelligence and threat correlation/hunting solutions, we will rely heavily on the established reputation and combined experience of our management team, specifically within intelligent and automated cybersecurity platforms. Members of our management team are globally recognized international speakers on cybersecurity specifically focusing on the topics of threat intelligence, ransomware, DDoS, cyber-crime trends, and cybersecurity careers and appear regularly as conference speakers and television security experts. We maintain a current web presence and share an online blog delivering the latest information on trends, threats, solutions, and general cybersecurity information.

 

In the past 12 months, we have been establishing brand recognition in the market through attending cybersecurity conferences and co-producing a cyber-crime TV series called “Dark Ops” which features Tego’s products in use in the episodes. We also have established strategic partnerships with technology resellers and service providers who are evangelizing Tego’s brand and products to their customer bases.

 

Our Products & Services

 

Products

 

Tego's threat intelligence feed is a combination of over 45 different open-sourced threat data and closed threat intelligence sources that are brought into the Tego threat intelligence platform. The Tego threat intelligence platform processes, deduplicates, and enriches the threat data/intelligence to provide additional context needed by Security Operations teams to investigate and remediate threats. Formatted in the Open Cybersecurity Schema Framework (OCSF) standard, the threat intelligence is provided to the customer in an easy to use format.

 

Tego's threat correlation and threat hunting application integrates directly into existing Security Information and Event Management (SIEM) and data lake solutions that provides enterprises the ability to quickly track threats, map out exposures, and expedite remediation to find the “signal in the noise.” With high performing and low latency searches, Tego's threat correlation engine saves security operations teams time and money in an environment where timing is everything as efforts are made to lower mean-time-to-detection (MTTD) and mean-time-to-response (MTTR). What makes Tego's threat correlation engine different from other cyber threat correlation applications, is that it is the first commercially available solution that was specifically developed for the customer’s existing SIEM or data lake platform. It operates within the customer’s existing SIEM or data lake environment, so security operations teams do not have to use multiple tools and views to complete a specific task or research a threat. Tego cross-correlates threats in real time and not only looks forward but also backwards in order to see if the organization’s network has been previously exposed (active foresight and hindsight).

 

The first version of the Tego threat detection engine is an integration with the industry-leading Splunk SIEM platform and is available for download via the Splunk app store (SplunkBase). A second integration has been developed for the Elastic SIEM platform. Tego also has developed the first fully-integrated threat detection engine for Amazon Security Lake.

 

 
4

Table of Contents

 

Tego also became the first threat intelligence provider on the Databricks Data Marketplace in June of 2023. A threat correlation integration for Databricks is currently under development with expected release in early 2024.

 

Services

 

We currently offer only one service: Cyber Threat Intelligence (CTI) reporting. CTI reporting provides individuals or enterprises with custom cyber threat intelligence on issues such as social media impersonation, compromised email credentials, look-a-like domains, social media trends and possible DarkWeb presence. Management has received many requests to leverage the threat intelligence used by Tego in a customized report and responded to this by developing a threat intelligence product aimed at providing real-time data to specific corporations and individuals. CTI reporting helps individuals and organizations understand the threats that have, will, or are currently directly targeting them. Tego’s CTI reporting service is provided in real time based on emerging threats and on customized cadences defined by the client. The cost to the client will depend on the size and complexity of the client’s cyber footprint.

 

Pricing

 

Products

 

We offer our products on a subscription basis. End users download the application and then pay a non-refundable subscription fee of $54,000 - $75,000 per annum per license for the threat detection engine or $500 - $1500 per month for the threat intelligence feed. Upon receipt of payment, we issue a license key to the end user to activate the application. Revenue generated from subscription fees are recognized as unearned revenue which are amortized over the of the life of the license contract which typically is one calendar year.

 

Services

 

CTI reporting will be offered on an as needed basis and typically generates a fee of $2,500 per report.

 

Competition

 

We compete with an array of established and emerging security software and services vendors. As organizations increasingly embrace cloud platforms, IoT and other new networking technologies, they are becoming increasingly exposed to ever evolving cybercrimes. The introduction of new technologies and market entrants will continue to fuel an intense competitive environment as companies seek solutions to cybersecurity breaches.

 

Our competitors include diversified security software and services vendors, threat correlation companies, and providers of threat intelligence platforms that compete with some of the features present in our solution such as Anomali, Recorded Future, Threat Quotient, Cyware, and Anvilogic.

 

We compete based on several factors, including product functionality; scope of offerings; performance; brand, reputation, and customer satisfaction; ease of implementation, use and service; price, scalability, reliability, and security.

 

We believe that we will compete favorably with respect to these factors and are well positioned as an emerging provider of threat intelligence and threat correlation/hunting solutions and services.

 

Strategic Partners and Suppliers

 

Our channel partners will provide us with additional leverage by assisting in closing customer transactions as part of larger security purchases, sourcing new prospects and securing maintenance renewals. Our first product integration is with Splunk Inc., a leader in Gartner’s 2020 Magic Quadrant (MQ) for SIEM platforms. Splunk is recognized worldwide for the highest overall ability to execute. Thousands of organizations use Splunk as their SIEM for security monitoring, advanced threat detection, incident investigation and forensics, incident response, SOC automation and a wide range of security analytics and operations use cases.

 

 
5

Table of Contents

 

In 2023, we established a strategic relationship with a Top 15 managed security service provider (MSSP) and became an approved vendor with TD SYNNEX.

 

Operations

 

We will continue to develop additional integrations for the Tego threat detection engine and add additional threat intelligence sources to the Tego threat intelligence feed. We expect continued growth in the number of cloud and SaaS operations experts, to further our goal of delivering the best experience for our customers. Accordingly, personnel-related costs within our SaaS development, threat intelligence platform, sales, and operations teams, will increase in line with our projected revenue model.

 

Sales and Marketing

 

Sales

 

The initial sales strategy will focus on marketing the advantages of the Tego threat detection engine to existing Splunk and Amazon Security Lake users. At present Splunk has 22,000+ customers, in 110 countries including 89 of the Fortune 100. Tego has hired an experienced Chief Revenue Officer (CRO) who has been assembling a dedicated inside sales team who are specifically trained to market Tego to organizations using the Splunk SIEM platform or Amazon Security Lake. Tego has also launched a channel partner initiative to foster meaningful, profitable relationships with leading cybersecurity consultants and solution providers. These channel partners will offer Tego as an upsell to their current clients already using the Splunk SIEM platform or Amazon Security Lake. Some partners are also offering professional services to move their customers from Splunk to Amazon, including Tego in the package.

 

Marketing

 

We continue to focus our marketing efforts on increasing the strength of the ‘TEGO’ brand, communicating product advantages and business benefits, generating leads for our sales teams and channel partners while driving product adoption. We will deliver targeted content to demonstrate our threat intelligence platform and use digital advertising methods to deliver opportunities to our sales teams. We will engage with existing customers to provide education and awareness to promote expanded use of our software. We will work with our own researchers, as well as the broader security community, to share important information about vulnerabilities and threats through the online community, social media, and traditional public relations.

 

Intellectual Property

 

To protect our unpatented proprietary technologies and processes, we rely on trade secret laws and confidentiality agreements with our employee(s), consultants, channel partners and vendors. At present our only intellectual property is the Tego threat intelligence platform and product integrations for threat correlation/hunting. We may rely on provisional patents in the near term, filing for full patent protection, as necessary.

 

Subsidiaries

 

We currently have no subsidiaries.

 

Employees

 

We currently employ 5 full-time employees and 2 part-time employees. Additionally, we have 12 contracted consultants.

 

Legal Proceedings

 

We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which our directors, officers or any affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

 
6

Table of Contents

 

Jumpstart Our Business Startups Act

 

In April 2012, the Jumpstart Our Business Startups Act ("JOBS Act") was enacted into law. The JOBS Act provides, among other things:

 

Exemptions for emerging growth companies from certain financial disclosure and governance requirements for up to five years and provides a new form of financing to small companies;

 

Amendments to certain provisions of the federal securities laws to simplify the sale of securities and increase the threshold number of record holders required to trigger the reporting requirements of the Securities Exchange Act of 1934;

 

Relaxation of the general solicitation and general advertising prohibition for Rule 506 offerings;

 

Adoption of a new exemption for public offerings of securities in amounts not exceeding $50 million; and

 

Exemption from registration by a non-reporting company of offers and sales of securities of up to $1,000,000 that comply with rules to be adopted by the SEC pursuant to Section 4(6) of the Securities Act and exemption of such sales from state law registration, documentation or offering requirements.

 

In general, under the JOBS Act, a company is an emerging growth company if its initial public offering ("IPO") of common equity securities was effected after December 8, 2011 and the company had less than $1 billion of total annual gross revenues during its last completed fiscal year. A company will no longer qualify as an emerging growth company after the earliest of:

 

 

(i)

the completion of the fiscal year in which the company has total annual gross revenues of $1 billion or more,

 

(ii)

the completion of the fiscal year of the fifth anniversary of the company's IPO;

 

(iii)

the company's issuance of more than $1 billion in nonconvertible debt in the prior three-year period, or

 

(iv)

the company becoming a "larger accelerated filer" as defined under the Securities Exchange Act of 1934.

 

 The JOBS Act provides additional new guidelines and exemptions for non-reporting companies and for non-public offerings.

 

Those exemptions that impact the Company are discussed below.

 

Financial Disclosure. The financial disclosure in a registration statement filed by an emerging growth company pursuant to the Securities Act of 1933 will differ from registration statements filed by other companies as follows:

 

 

(i)

audited financial statements required for only two fiscal years;

 

(ii)

selected financial data required for only the fiscal years that were audited;

 

(iii)

executive compensation only needs to be presented in the limited format now required for smaller reporting companies.

 

(A smaller reporting company is one with a public float of less than $75 million as of the last day of its most recently completed second fiscal quarter).

 

However, the requirements for financial disclosure provided by Regulation S-K promulgated by the Rules and Regulations of the SEC already provide certain of these exemptions for smaller reporting companies. The Company is a smaller reporting company. Currently a smaller reporting company is not required to file as part of its registration statement selected financial data and only needs audited financial statements for its two most current fiscal years and no tabular disclosure of contractual obligations.

 

The JOBS Act also exempts the Company's independent registered public accounting firm from complying with any rules adopted by the Public Company Accounting Oversight Board ("PCAOB") after the date of the JOBS Act's enactment, except as otherwise required by SEC rule.

 

The JOBS Act also exempts an emerging growth company from any requirement adopted by the PCAOB for mandatory rotation of the Company's accounting firm or for a supplemental auditor report about the audit.

 

 
7

Table of Contents

 

Internal Control Attestation. The JOBS Act also provides an exemption from the requirement of the Company's independent registered public accounting firm to file a report on the Company's internal control over financial reporting, although management of the Company is still required to file its report on the adequacy of the Company's internal control over financial reporting.

 

Section 102(a) of the JOBS Act exempts emerging growth companies from the requirements in §14A(e) of the Securities Exchange Act of 1934 for companies with a class of securities registered under the 1934 Act to hold shareholder votes for executive compensation and golden parachutes.

 

Other Items of the JOBS Act. The JOBS Act also provides that an emerging growth company can communicate with potential investors that are qualified institutional buyers or institutions that are accredited to determine interest in a contemplated offering either prior to or after the date of filing the respective registration statement. The Act also permits research reports by a broker or dealer about an emerging growth company regardless if such report provides sufficient information for an investment decision. In addition, the JOBS Act precludes the SEC and FINRA from adopting certain restrictive rules or regulations regarding brokers, dealers and potential investors, communications with management and distribution of a research reports on the emerging growth company IPO.

 

Section 106 of the JOBS Act permits emerging growth companies to submit 1933 Act registration statements on a confidential basis provided that the registration statement and all amendments are publicly filed at least 21 days before the issuer conducts any road show. This is intended to allow the emerging growth company to explore the IPO option without disclosing to the market the fact that it is seeking to go public or disclosing the information contained in its registration statement until the company is ready to conduct a roadshow.

 

Election to Opt Out of Transition Period. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a 1933 Act registration statement declared effective or do not have a class of securities registered under the 1934 Act) are required to comply with the new or revised financial accounting standard.

 

The JOBS Act provides a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of the transition period.

 

Item 1.A Risk Factors

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Item 1.B Unresolved Staff Comments

 

None.

 

Item 2. Properties

 

Our executive offices are located at 8565 South Eastern Avenue, Suite 150 Las Vegas, Nevada 89123. This space is sufficient to meet our needs, however, once we expand our business to a significant degree, we will have to find a larger space. We do not foresee any significant difficulties in obtaining any required additional space. We do not currently own any real property.

 

Item 3. Legal Proceedings

 

From time to time, we may become subject to various legal proceedings that are incidental to the ordinary conduct of its business. Although we cannot accurately predict the amount of any liability that may ultimately arise with respect to any of these matters, it makes provision for potential liabilities when it deems them probable and reasonably estimable. These provisions are based on current information and legal advice and may be adjusted from time to time according to developments.

  

We know of no material, existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest. 

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

 
8

Table of Contents

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity

 

Common Stock

 

Our Articles of Incorporation authorize us to issue 100,000,000 shares of common stock, par value $0.001.

 

The following statements relating to the capital stock set forth the material terms of the securities of our company. Reference is also made to the more detailed provisions of the certificate of incorporation and the by-laws, copies of which are filed as exhibits to this registration statement. 

 

Voting Rights: Except as otherwise required by law or as may be provided by the resolutions of the board of directors authorizing the issuance of Common Stock, all rights to vote and all voting power shall be vested in the holders of Common Stock. Each share of Common Stock shall entitle the holder thereof to one vote.

 

No Cumulative Voting: Except as may be provided by the resolutions of the board of directors authorizing the issuance of Common Stock, cumulative voting by any shareholder is expressly denied.

 

No Preemptive Rights: Preemptive rights shall not exist with respect to shares of Common Stock or securities convertible into shares of Common Stock of the Company.

 

Dividends: We have not paid any cash dividends on our Common Stock since inception and presently anticipate that all earnings, if any, will be retained for development of our business and that no dividends on our Common Stock will be declared in the foreseeable future. Any future dividends will be subject to the discretion of our Board of Directors and will depend upon, among other things, future earnings, operating and financial condition, capital requirements, general business conditions and other pertinent facts. Therefore, there can be no assurance that any dividends on our Common Stock will be paid in the future.

 

Rights upon Liquidation, Dissolution or Winding-Up of the Company: Upon any liquidation, dissolution or winding-up of our company, whether voluntary or involuntary, the remaining net assets shall be distributed pro rata to the holders of the Common Stock.

 

Preferred Stock

 

We have no preferred stock authorized.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

On December 8, 2021, our Board of Directors approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for us, and non-employee members of our Board of Directors, with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards. We have 10,000,000 common stock shares authorized under the Equity Compensation Plan

 

 
9

Table of Contents

 

Stock Options

 

During the year ended June 30, 2023, we had outstanding a total of 6,000,000 non-qualified stock options (the “options”) to directors, officers and certain key consultants. These options are subject to the terms and conditions of the Equity Compensation Plan. All granted options are subject to a five-year vesting schedule equal to 20% per year starting on the 1st day of each year following the effective date. All options have an exercise price of $0.65 which was the closing price of our common stock on the day the day granted.

 

The following is a continuity schedule for the Company’s outstanding non-qualified stock options: 

 

 

 

Number of

options

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

6,000,000

 

 

$0.65

 

Granted

 

 

125,000

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

125,000

 

 

 

-

 

Outstanding, June 30, 2023

 

 

6,000,000

 

 

$0.65

 

 

As of June 30, 2023, the Company had the following stock options outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted Average

 Life (Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

25,000

 

 

$0.65

 

 

 

8.52

 

 

January 3, 2032

 

January 4, 2022

 

 

5,750,000

 

 

 

1,150,000

 

 

 

0.65

 

 

 

8.52

 

 

January 4, 2032

 

March 1, 2023

 

 

125,000

 

 

 

25,000

 

 

 

0.65

 

 

 

8.52

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

1,200,000

 

 

$0.65

 

 

 

8.52

 

 

 

 

 

Performance Stock Units

 

During the year ended June 30, 2023, we had outstanding a total of 2,700,000 performance stock units (“performance units”) to directors, officers and certain key consultants. These performance units are subject to the terms and conditions of the Equity Compensation Plan. The performance units will be earned and vest upon reaching certain market capitalization goals during the performance period ending on December 31, 2026. The following table sets forth the number of performance stock units, their vesting conditions and expiry dates.

 

Each unit represents one common share:

 

Number of Performance Units

 

 

Vesting Conditions

 

Expiry Dates

 

900,000

 

 

Market capitalization of the Company reaches $50 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $75 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $100 million

 

December 31, 2026

 

 
10

Table of Contents

 

The following is a continuity schedule for the Company’s outstanding performance stock units:

 

 

 

Number of

Performance Units

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

-

 

 

 

-

 

Exercised

 

 

(900,000 )

 

 

 

 

Forfeited or cancelled

 

 

(400,000 )

 

 

-

 

Outstanding, June 30, 2023

 

 

2,700,000

 

 

$-

 

 

Warrants

 

On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $148,438 using the Black Scholes Option Pricing Model. These warrants expired during the three months ended March 31, 2023.

 

On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $399,087 using the Black Scholes Option Pricing Model.

 

On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $196,399 using the Black Scholes Option Pricing Model.

 

On July 12, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $249,971 using the Black Scholes Option Pricing Model and they were recorded at $102,943 in additional paid-in capital using the relative fair value method.

 

On July 15, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $124,984 using the Black Scholes Option Pricing Model and they were recorded at $51,471 in additional paid-in capital using the relative fair value method.

 

On July 18, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $124,994 using the Black Scholes Option Pricing Model and they were recorded at $51,474 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $220,526 using the Black Scholes Option Pricing Model and they were recorded at $59,265 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $110,263 using the Black Scholes Option Pricing Model and they were recorded at $29,633 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $110,263 using the Black Scholes Option Pricing Model and they were recorded at $29,633 in additional paid-in capital using the relative fair value method.

 

 
11

Table of Contents

 

On March 12, 2023, the Company granted 2,500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $1,847,450 using the Black Scholes Option Pricing Model.

 

The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants. 

 

 

 

June 30, 2023

 

Stock price

 

$0.25 - 0.83

 

Risk-free interest rate

 

1.06%-4.213

%

Expected life

 

2 - 5 Years

 

Expected dividend rate

 

 

0

 

Expected volatility

 

100.00–195.25

%

 

Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows: 

 

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

4,500,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

(3,014,246 )

 

 

-

 

Outstanding, June 30, 2023

 

 

4,500,000

 

 

$0.25

 

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Expiry

Date

 

July 12, 2022

 

 

500,000

 

 

 

500,000

 

 

$0.25

 

 

July 12, 2027

 

July 15, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

July 15, 2027

 

July 18, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

July 18, 2027

 

October 13, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

October 13, 2027

 

March 12, 2023

 

 

2,500,000

 

 

 

2,500,000

 

 

 

0.25

 

 

March 12, 2028

 

Total

 

 

4,500,000

 

 

 

4,500,000

 

 

$0.25

 

 

 

 

 

Dividend Policy 

 

We have never paid any cash dividends and intend, for the foreseeable future, to retain any future earnings for the development of our business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our results of operations, financial condition, capital requirements and investment opportunities.

 

Holders

 

As of January 17, 2024, we have 53,776,616 issued and outstanding shares of Common Stock, which are held by approximately 266 shareholders of record.

 

 
12

Table of Contents

 

Transfer Agent and Registrar

 

Tego Cyber Inc. has appointed Signature Stock Transfer Inc. as its transfer agent. Signature’s address is 14673 Midway Road, Suite #220, Addison, Texas, 75001. The transfer agent is responsible for all record-keeping and administrative functions in connection with the common shares.

 

Market Information

 

Our common shares are currently quoted on the OTCQB under the symbol "TGCB”. The following table sets forth the range of the high and low sale prices of the common stock for the periods indicated. The quotations reflect inter-dealer prices, without retail markup, markdown or commission, and may not represent actual transactions. Consequently, the information provided below may not be indicative of our common stock price under different conditions.

 

Period Ended

 

High

 

 

Low

 

Year Ended June 30, 2023

 

 

 

 

 

 

June 30, 2023

 

$0.45

 

 

$0.90

 

March 31, 2023

 

$1.10

 

 

$0.18

 

December 31, 2022

 

$0.52

 

 

$0.31

 

September 30, 2022

 

$0.52

 

 

$0.25

 

Year Ended June 30, 2022

 

 

 

 

 

 

 

 

June 30, 2022

 

$0.80

 

 

$0.53

 

March 31, 2022

 

$0.94

 

 

$0.53

 

December 31, 2021

 

$0.90

 

 

$0.52

 

September 30, 2021

 

$0.97

 

 

$0.51

 

 

As of January 17, 2024, the highest trading price of our common stock was $1.10 per share and the lowest trading price was $0.045 per share. As of January 17, 2024, there were 53,776,616 shares of common stock outstanding held by approximately 266 stockholders of record.

 

Trades in our common stock may be subject to Rule 15g-9 of the Exchange Act, which imposes requirements on broker/dealers who sell securities subject to the rule to persons other than established customers and accredited investors. For transactions covered by the rule, broker/dealers must make a special suitability determination for purchasers of the securities and receive the purchaser’s written agreement to the transaction before the sale.

 

Penny Stock Regulation

 

Penny stocks generally are equity securities with a price of less than $5.00 per share other than securities registered on national securities exchanges or listed on the Nasdaq Stock Market, provided that current price and volume information with respect to transactions in such securities are provided by the exchange or system. The penny stock rules impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors (generally those with assets in excess of $1,000,000 or annual income exceeding $200,000, or $300,000 together with their spouse). For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser's written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction, of a disclosure schedule prescribed by the SEC relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative and current quotations for the securities. Finally, monthly statements must be sent disclosing recent price information on the limited market in penny stocks. Because of these penny stock rules, broker-dealers may be restricted in their ability to sell our common stock. The foregoing required penny stock restrictions will not apply to our common stock if such stock reaches and maintains a market price of $5.00 per share or greater.

 

 
13

Table of Contents

 

Additional Information

 

We refer you to our Articles of Incorporation, Bylaws, and the applicable provisions of the Nevada Revised Statues for a more complete description of the rights and liabilities of holders of our securities.

 

Item 6. [Reserved]

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes to the financial statements included elsewhere in this Registration Statement. Some of the statements under “Management’s Discussion and Analysis,” “Description of Business” and elsewhere herein may include forward-looking statements which reflect our current views with respect to future events and financial performance. These statements include forward-looking statements both with respect to us specifically and the renewable energy industry in general. Statements which include the words “expect,” “intend,” “plan,” “believe,” “project,” “anticipate,” “will,” and similar statements of a future or forward-looking nature identify forward-looking statements for purposes of the federal securities laws or otherwise. The safe harbor provisions of the federal securities laws do not apply to any forward-looking statements contained in this Registration Statement. All forward-looking statements address such matters that involve risks and uncertainties. Accordingly, there are or will be important factors that could cause our actual results to differ materially from those indicated in these statements. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise. If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Any forward-looking statements you read herein reflect our current views with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to our written and oral forward-looking statements attributable to us or individuals acting on our behalf and such statements are expressly qualified in their entirety by this paragraph.

 

Overview

 

We were incorporated in the State of Nevada on September 6, 2019. We were founded to mitigate the disparity in the rapidly evolving cyber threat hunting, correlation, and threat intelligence market. The Company is focused on developing solutions for threat intelligence and autonomous threat hunting/correlation. Tego’s curated threat intelligence feed not only contains a comprehensive list of indicators of compromise, but also provides additional context including specific details needed to counteract threats so that security teams can spend less time searching for disjointed indicators of compromise. Tego’s threat correlation engine integrates with top security and data lake platforms to proactively identify threats. The Tego threat correlation engine allows security teams to find threats faster using curated data feeds, powerful and low latency searches across large disparate data sets, and user-friendly visualizations that help reduce the time to detection and response.  For more information, please visit https://tegocyber.com.

 

Results of operations for fiscal year ended June 30, 2023 compared to year ended June 30, 2022

 

Revenues

 

We are in development stage and generated $NIL of revenue for the fiscal year ended June 30, 2023 compared to $1,050 for the fiscal year ended June 30, 2022.

 

 
14

Table of Contents

 

Operating Expenses

 

We incurred total operating expenses of $5,830,693 for the fiscal year ended June 30, 2023, compared to $3,085,319 for the fiscal year ended June 30, 2022. These amounts consisted of the following:

 

 

 

For Year Ended

June 30, 2023

 

 

For Year Ended

June 30, 2022

 

General & administration

 

$4,878,234

 

 

$1,258,539

 

Professional fees

 

 

582,565

 

 

 

749,607

 

Sales & marketing

 

 

369,894

 

 

 

171,211

 

Share-based compensation

 

 

-

 

 

 

905,962

 

Impairment of software

 

 

 

 

 

 

 

Total operating expenses

 

$5,830,693

 

 

$3,085,319

 

 

Overall operating expenses increased by $2,745,374 to $5,830,693 for the year ended June 30, 2023, as compared to $3,085,319 for the year ended June 30, 2022. General and administration increased by $3,619,695 due to an increase of operational expenses due to the growth of the overall business and ongoing development of the infrastructure in preparation of full commercialization of the first version of the Tego threat detection engine and threat intelligence feed.

 

Professional fees decreased by $167,042 as a result of the completion of the initial public offering. Sales and marketing increased by $198,683 due to increased spending setting up and implementing the path to market strategy for the first version of the Tego threat application.

 

Net Loss

 

We incurred a net loss of $10,738,393 for the fiscal year ended June 30, 2023, compared to a net loss of $3,147,901 for the fiscal year ended June 30, 2022.

 

Liquidity and Capital Resources

 

As at June 30, 2023, we have a working capital deficit of $809,495, a net loss of $10,738,393 and have earned limited revenue to cover our operating costs. We have $181,246 cash on hand and our burn rate is approximately $150,000 per month. We intend to fund future operations through debt or equity financing arrangements. Our ability to realize our business plan is dependent upon, among other things, obtaining additional financing to continue operations, and development of our business plan. In response to these problems, management intends to raise additional funds through debt, public or private placement offerings. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Cash Flow from Operating Activities

 

For the fiscal year ended June 30, 2023, the net cash flows used in our operating activities was $1,645,851 compared to $1,618,526 for the same period ended June 30, 2022. This amount was primarily related to a (i) net loss of $10,738,393; (ii) share issued for services valued at $2,096,304; (iii) share based compensation of $1,993,585; and (iv) financing fees in settlement of default of $3,522,449.

 

Cash Flow from Investing Activities

 

For the fiscal year ended June 30, 2023, the net cash used in investing activities by the Company was $327,645 compared to $341,949 for the same period ended June 30, 2022. The amount was related to the capitalization of software development costs.

 

Cash Flow from Financing Activities

 

For the fiscal year ended June 30, 2023, the net cash provided by financing activities by the Company was $2,107,000 compared to $1,425,202 for the same period ended June 30, 2022. This amount was related to cash received from the sale of our common stock of $1,297,000 and cash received from issuance of notes payable of $810,000.

 

 
15

Table of Contents

 

Contractual Obligations

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Future Financings

 

We will continue to rely on equity sales of our common shares and debt proceeds in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.

 

Expected Purchase or Sale of Significant Equipment

 

We do not anticipate the purchase or sale of any significant equipment, as such items are not required by us at this time or in the next twelve months.

 

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Critical Accounting Policies

 

This summary of significant accounting policies is presented to assist in understanding the financial statements. The financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of the financial statements.

 

Basis of Preparation

 

The accompanying financial statements have been prepared to present the balance sheets the statements of operations, statements of changes in shareholders’ equity and cash flows of the Company for the fiscal year ended June 30, 2023 and have been prepared in accordance with US GAAP.

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. During the fiscal periods ended June 30, 2023 and 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

 

Cash

 

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

 

 
16

Table of Contents

 

Receivables and Allowance for Doubtful Accounts

 

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the period ended June 30, 2023, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of June 30, 2023, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

 

Fair Value of Financial Instruments

 

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivables, subscription receivables, and accounts payable and accrued liabilities, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

Management believes it is not practical to estimate the fair value of related party receivables and payables because the transactions cannot be assumed to have been consummated at arm’s length, the terms are not deemed to be market terms, there are no quoted values available for these instruments, and an independent valuation would not be practical due to the lack of data regarding similar instruments, if any, and the associated potential costs.

 

Revenue Recognition

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), was adopted by the Company as of September 6, 2019. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and have been primarily from consulting and management services, and the Company has no significant post-delivery obligations, this new standard did not result in a material recognition of revenue on the Company’s accompanying financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from providing consulting and management services under Topic 606 is recognized in a manner that reasonably reflects the delivery of services to customers in return for expected consideration and includes the following elements:

 

 

-

executed contracts with the Company’s customers that it believes are legally enforceable;

 

-

identification of performance obligations in the respective contract;

 

-

determination of the transaction price for each performance obligation in the respective contract;

 

-

allocation of the transaction price to each performance obligation; and

 

-

recognition of revenue only when the Company satisfies each performance obligation.

 

 
17

Table of Contents

 

These five elements as applied to the Company’s consulting and management services results in revenue recorded as services are provided.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

 

Earnings per Share

 

Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings per share. The following table summarizes the securities outstanding and exercisable, (regardless of exercise price) at June 30, 2023 and 2022 that were excluded from the diluted net loss per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss.

 

 

 

2023

 

 

2022

 

Potentially dilutive common share equivalents

 

 

 

 

 

 

Options

 

 

1,200,000

 

 

 

-

 

Warrants

 

 

4,500,000

 

 

 

3,014,246

 

Performance Stock Units

 

 

2,700,000

 

 

 

4,000,000

 

Potentially dilutive shares outstanding

 

 

8,400,000

 

 

 

7,014,246

 

 

Recently Issued Accounting Pronouncements

 

In June 2018, the Financial Accounting Standards Board (the “FASB”) issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting”, to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 simplifies the accounting for nonemployee share-based payments, aligning it more closely with the accounting for employee awards.

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) did not or are not expected to have a material impact on the Company's present or future financial statements.

 

Item 7.A Quantitative and Qualitative Disclosures about Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Item 8. Financial Statements and Supplementary Data.

 

 
18

Table of Contents

 

TABLE OF CONTENTS

 

Report of Independent Registered Public Accounting Firm M&K CPAS PLLC PCAOB ID:2738

 

20

 

 

 

 

 

Report of Independent Registered Public Accounting Firm, BF Borgers CPA PC PCAOB ID:5041

 

21

 

 

 

 

 

FINANCIAL STATEMENTS

 

 

 

 

 

 

 

 

 

Balance Sheets as of June 30, 2023 and June 30, 2022

 

22

 

 

 

 

 

 

 

Statement of Operations for the years ended June 30, 2023 and 2022

 

23

 

 

 

 

 

 

 

Statement of Changes in Shareholders’ Equity for the years ended June 30, 2023 and 2022

 

24

 

 

 

 

 

 

 

Statement of Cash Flows for the years ended June 30, 2023 and 2022

 

25

 

 

 

 

 

 

 

Notes to the Financial Statements

 

26-44

 

 

 
19

Table of Contents

 

 tgcb_10kimg1.jpg

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Tego Cyber, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheet of Tego Cyber Inc. (the Company) as of June 30, 2023, and the related statements of operations, changes in shareholders’ equity, and cash flows for the year June 30, 2023, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2023, and the results of its operations and its cash flows for the year ended June 30, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has sustained net losses, has a net capital deficiency, and has generated negative cash flows from operations which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are discussed in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

Black Scholes Calculations

 

As discussed in Note 10 to the Financial Statements, the Company utilizes Black Scholes calculations to determine fair value of the Company’s stock options and warrants.

 

Auditing management’s calculations of fair value of stock options involves significant judgements and estimates to determine the proper value.  Volatility and term are the major assumptions used by management in determining the value of the stock options.

 

To evaluate the appropriateness of fair value calculation, we evaluated management’s significant judgements and estimates in what inputs were utilized within the Black Scholes calculations.

 

/s/M&K CPAS, PLLC

 

 

We have served as the Company’s auditor since 2023.

 

 

The Woodlands, TX

 

January 17, 2024

 

 
20

Table of Contents

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Shareholders of Tego Cyber, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheet of Tego Cyber, Inc. (the “Company”) as of June 30, 2022, and the related statement of operations, stockholders’ equity, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2022, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

/S/ BF Borgers CPA PC

BF Borgers CPA PC

 

Served as auditor since 2022

Lakewood, CO

November 10, 2022

 

 
21

Table of Contents

 

TEGO CYBER INC.

BALANCE SHEETS

(Expressed in US Dollars)

 

 

 

June 30,

2023

 

 

June 30,

2022

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$181,246

 

 

$47,742

 

Accounts receivable

 

 

-

 

 

 

1,150

 

Prepaid expenses (Note 5)

 

 

30,226

 

 

 

41,119

 

Total current assets

 

 

211,472

 

 

 

90,011

 

Other assets

 

 

25,000

 

 

 

25,000

 

Computer equipment, net

 

 

-

 

 

 

3,207

 

Software (Note 6)

 

 

-

 

 

 

411,122

 

TOTAL ASSETS

 

$236,472

 

 

$529,340

 

 

 

 

 

 

 

 

 

 

LIABILITIES & SHAREHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable (Note 7)

 

$129,273

 

 

$66,066

 

Notes payable (Note Convertible debts

 

 

891,694

 

 

 

-

 

TOTAL LIABILITIES

 

 

1,020,967

 

 

 

66,066

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Common shares 100,000,000 shares authorized $0.001 par value 47,343,282 shares issued and outstanding at June 30, 2023 and 25,508,044 shares at June 30, 2022

 

 

47,343

 

 

 

25,508

 

Additional paid in capital

 

 

14,054,838

 

 

 

4,586,049

 

Accumulated deficit

 

 

(14,886,676 )

 

 

(4,148,283 )

 

 

 

 

 

 

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

 

 

(784,495 )

 

 

463,274

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY

 

$236,472

 

 

$529,340

 

 

The accompanying notes are an integral part of these financial statements

 

 
22

Table of Contents

 

TEGO CYBER INC.

STATEMENTS OF OPERATIONS

(Expressed in US Dollars)

 

 

 

Year Ended

June 30,

2023

 

 

Year Ended

June 30,

2022

 

REVENUE

 

 

 

 

 

 

Consulting fees

 

$-

 

 

$1,050

 

Subscription Revenue

 

 

-

 

 

 

2,500

 

TOTAL REVENUE

 

 

-

 

 

 

3,550

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

General & administration

 

 

4,878,234

 

 

 

1,258,539

 

Professional fees

 

 

582,565

 

 

 

749,607

 

Sales & marketing

 

 

369,894

 

 

 

171,211

 

Share based compensation

 

 

-

 

 

 

905,962

 

TOTAL OPERATING EXPENSES

 

 

5,830,693

 

 

 

3,085,319

 

 

 

 

 

 

 

 

 

 

NET OPERATING LOSS

 

 

(5,830,693 )

 

 

(3,081,769 )

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

Accretion expense

 

 

(653,980 )

 

 

(66,132 )

Financing fees

 

 

(3,607,449 )

 

 

-

 

Impairment of software

 

 

(646,271)

 

 

-

 

TOTAL OTHER INCOME (EXPENSE)

 

 

(4,907,700 )

 

 

(66,132 )

 

 

 

 

 

 

 

 

 

NET LOSS

 

$(10,738,393 )

 

$(3,147,901 )

 

 

 

 

 

 

 

 

 

BASIC AND DILUTED LOSS PER COMMON SHARE

 

$(0.33 )

 

$(0.13 )

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

32,871,748

 

 

 

24,184,384

 

 

The accompanying notes are an integral part of these financial statements

 

 
23

Table of Contents

 

TEGO CYBER INC.

STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE YEARS ENDED JUNE 30, 2023 AND JUNE 30, 2022

(Expressed in US Dollars)

 

 

 

Number

of Shares

 

 

Common

Stock

 

 

Additional

Paid-In

Capital

 

 

Subscriptions

Receivable

 

 

Accumulated Deficit

 

 

Total

Shareholder

Equity

 

Balances, June 30, 2021

 

 

18,296,511

 

 

$18,297

 

 

$1,720,631

 

 

$(10,500 )

 

$(1,000,382 )

 

$728,046

 

Shares issued for cash

 

 

5,558,810

 

 

 

5,558

 

 

 

1,409,144

 

 

 

10,500

 

 

 

-

 

 

 

1,425,202

 

Shares issued for services

 

 

715,572

 

 

 

716

 

 

 

457,534

 

 

 

-

 

 

 

-

 

 

 

458,250

 

Shares issued for settlement of

convertible debts

 

 

937,151

 

 

 

937

 

 

 

92,778

 

 

 

-

 

 

 

-

 

 

 

93,715

 

Share-based compensation

 

 

-

 

 

 

-

 

 

 

905,962

 

 

 

-

 

 

 

-

 

 

 

905,962

 

Net loss for the year ended June 30, 2022

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,147,901 )

 

 

(3,147,901 )

Balances, June 30, 2022

 

 

25,508,044

 

 

$25,508

 

 

$4,586,049

 

 

$-

 

 

$(4,148,283 )

 

$463,274

 

Shares issued as transaction costs for notes payable

 

 

1,533,333

 

 

 

1,534

 

 

 

246,333

 

 

 

-

 

 

 

-

 

 

 

247,867

 

Warrants issued as transaction costs for notes payable

 

 

 -

 

 

 

 -

 

 

 

 324,419

 

 

 

 

 

 

 

 

 

 

 

 324,419

 

Shares issued for services

 

 

3,953,572

 

 

 

3,953

 

 

 

2,092,351

 

 

 

-

 

 

 

-

 

 

 

2,096,304

 

Shares issued from private placements

 

 

12,970,000

 

 

 

12,970

 

 

 

1,284,030

 

 

 

-

 

 

 

-

 

 

 

1,297,000

 

Shares issued for debts

 

 

45,000

 

 

 

45

 

 

 

8,955

 

 

 

-

 

 

 

-

 

 

 

9,000

 

Share-based compensation

 

 

1,100,000

 

 

 

1,100

 

 

 

1,992,485

 

 

 

-

 

 

 

-

 

 

 

1,993,585

 

Shares issued for financing fees

 

 

2,233,333

 

 

 

2233

 

 

 

1,672,766

 

 

 

-

 

 

 

-

 

 

 

1,674,999

 

Warrants issued for financing fees

 

 

-

 

 

 

-

 

 

 

1,847,450

 

 

-

 

 

 

-

 

 

 

1,847,450

 

Net loss for the year ended June 30, 2023

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(10,738,393 )

 

 

(10,738,393 )

Balances, June 30, 2023

 

 

47,343,282

 

 

$47,343

 

 

$14,054,838

 

 

$-

 

 

$(14,886,676 )

 

$(784,495 )

 

The accompanying notes are an integral part of these financial statements

 

 
24

Table of Contents

 

TEGO CYBER INC.

STATEMENTS OF CASH FLOWS

(Expressed in US Dollars)

 

 

 

  Year Ended

June 30,

2023

 

 

Year Ended

 June 30,

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss for the year

 

$(10,738,393 )

 

$(3,147,901 )

Items not affecting cash

 

 

 

 

 

 

 

 

Shares issued for services

 

 

2,096,304

 

 

 

458,250

 

Interest on short term debt

 

 

-

 

 

 

4,962

 

Amortization

 

 

95,703

 

 

 

3,370

 

Accretion expense

 

 

653,980

 

 

 

66,132

 

Impairment of software

 

 

646,271

 

 

 

-

 

Share-based compensation

 

 

1,993,585

 

 

 

905,962

 

Financing fees in settlement of default

 

 

3,522,449

 

 

 

-

 

Changes in non-cash working capital items:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

1,150

 

 

 

300

 

Prepaid expenses

 

 

10,893

 

 

 

47,343

 

Accounts payable and accrued liabilities

 

 

72,207

 

 

 

43,056

 

NET CASH USED IN OPERATING ACTIVITIES

 

 

(1,645,851 )

 

 

(1,618,526 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Purchase of computer equipment

 

 

-

 

 

 

(6,577 )

Capitalized software development costs

 

 

(327,645 )

 

 

(335,372 )

NET CASH USED IN INVESTING ACTIVITIES

 

 

(327,645 )

 

 

(341,949 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from shares issued

 

 

-

 

 

 

1,425,202

 

Proceeds from private placements

 

 

1,297,000

 

 

 

-

 

Cash received from issuance of notes payable

 

 

810,000

 

 

 

-

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

 

 

2,107,000

 

 

 

1,425,202

 

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH

 

 

133,504

 

 

 

(535,273 )

CASH AT BEGINNING OF THE PERIOD

 

 

47,742

 

 

 

583,015

 

CASH AT END OF THE PERIOD

 

$181,246

 

 

$47,742

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Shares issued as transaction costs with notes payable

 

$572,286

 

$-

 

Shares issued for settlement of debt

 

$9,000

 

 

$93,715

 

 

The accompanying notes are an integral part of these audited financial statements 

 

 
25

Table of Contents

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Tego Cyber Inc. is an early-stage company which was incorporated in the State of Nevada on September 6, 2019. Our year end is June 30. We are a development stage enterprise. We are engaged in the business of the development and commercialization of innovative cybersecurity applications that help enterprises reduce risk, remediate cyber-attacks, and protect intellectual property and data.

 

Our principal office is located at 8565 South Eastern Avenue, Suite 150, Las Vegas, Nevada, 89123. Our telephone number is (855) 939-0100 and our general e-mail contact is info@tegocyber.com. Our website can be viewed at www.tegocyber.com.

 

NOTE 2 – BASIS OF PRESENTATION

 

The accompanying audited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). In the opinion of management, the financial statements include all adjustments of a normal recurring nature necessary for a fair statement of the results for the period presented.

 

The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and the statements of cash flows of the Company for the years ended June 30, 2023 and 2022. The accompanying audited financial statements have been prepared in accordance with US GAAP using Company-specific information where available and allocations and estimates where data is not maintained on a Company-specific basis within its books and records. Due to the allocations and estimates used to prepare the financial statements, they may not reflect the financial position, cash flows and results of operations of the Company in the future or its operations, cash flows and financial position.

 

The preparation of financial statements in accordance with US GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of the Company’s financial position and results of operations.

 

NOTE 3 – GOING CONCERN UNCERTAINTY

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At June 30, 2023, the Company had a working capital deficit of $809,495. For the year ended June 30, 2023, the Company sustained net losses of $10,738,393 and generated negative cash flows from operations of $1,645,851. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

 

NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the financial statements. The financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of the financial statements.

 

 

 
26

Table of Contents

 

Basis of Preparation

 

The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and statements of cash flows of the Company for the period ended June 30, 2023 and 2022 and have been prepared in accordance with US GAAP.

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at June 30, 2023, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

 

Cash

 

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

 

Receivables and Allowance for Doubtful Accounts

 

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the period ended June 30, 2023 and 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of June 30, 2023 and 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

 

Software

 

Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years. During the year ended June 30, 2023, management identified indicators of impairment on its software and software under development. The indicators consisted of a current and historic cash flow loss from operations. As a result, management performed an impairment test that resulted in the recognition of an impairment loss of $646,271 on the software assets.  

 

Research and Development Costs

 

Research and Development Costs are expensed as incurred. During the years ended June 30, 2023 and 2022, the Company incurred $nil research and development costs.

 

Advertising Costs

 

Advertising Costs are expensed as incurred. During the years ended June 30, 2023 and 2022, the Company incurred $nil advertising costs.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

 

 

 
27

Table of Contents

 

Fair Value of Financial Instruments

 

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at June 30, 2023. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.

 

Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.

 

Revenue Recognition

 

Revenue is recognized under ASC 606, “Revenue from Contracts with Customers” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services.

 

Revenue for the fiscal years ended June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Consulting fees

 

$-

 

 

$1,050

 

Subscription revenue

 

 

-

 

 

 

2,500

 

Total

 

$-

 

 

$3,550

 

 

 
28

Table of Contents

 

 

The Company currently has not generated any revenue from its threat intelligence software.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. Dilutive securities are not included in the weighted average number of shares when inclusion would be anti-dilutive. The following table summarizes the securities outstanding and exercisable, (regardless of exercise price) at June 30, 2023 and 2022 that were excluded from the diluted net loss per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss.

 

 

 

2023

 

 

2022

 

Potentially dilutive common share equivalents

 

 

 

 

 

 

Options

 

 

1,200,000

 

 

 

-

 

Warrants

 

 

4,500,000

 

 

 

3,014,246

 

Performance Stock Units

 

 

2,700,000

 

 

 

4,000,000

 

Potentially dilutive shares outstanding

 

 

8,400,000

 

 

 

7,014,246

 

 

Recently Issued Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.

 

 

 
29

Table of Contents

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

NOTE 5 – PREPAID EXPENSES

 

Prepaid expense balance as of June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Advertising & promotion

 

$-

 

 

$5,500

 

Consultants & contractors

 

 

-

 

 

 

5,301

 

Platform costs

 

 

-

 

 

 

30,318

 

Software development

 

 

30,226

 

 

 

-

 

Total

 

$30,226

 

 

$41,119

 

 

NOTE 6 – SOFTWARE

 

The Company has completed the first version of its technology for integration with the Splunk SIEM platform. That product is now commercially available. The Company is currently developing versions of its application for integration with AWS Security Lake and Elastic SIEM platform.

 

Balance, June 30, 2021

 

$75,750

 

Additions

 

 

335,372

 

Depreciation

 

 

-

 

Balance, June 30, 2022

 

 

411,122

 

Additions

 

 

327,645

 

Depreciation

 

 

(92,496 )

Impairment

 

 

(646,271 )

Balance, June 30, 2023

 

$-

 

 

During the year ended June 30, 2023, management identified indicators of impairment on its software and software under development. The indicators consisted of a current and historic cash flow loss from operations. As a result, management performed an impairment test that resulted in the recognition of an impairment loss of $646,271 on the software assets.

 

NOTE 7 – ACCOUNTS PAYABLE

 

Accounts payable balance as of June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Advertising & promotion

 

$45,000

 

 

$-

 

Legal & accounting

 

 

38,988

 

 

 

23,247

 

Software development

 

 

41,415

 

 

 

42,819

 

Travel

 

 

1,358

 

 

 

-

 

Accrued interest on short term debt

 

 

2,512

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total

 

$129,273

 

 

$66,066

 

 

 
30

Table of Contents

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Shannon Wilkinson, a Director, CEO, President, Secretary and Treasurer of the Company, for management fees of $Nil (June 30, 2022 - $101,750), gross wages of $122,500 (June 30, 2022 - $98,692) and on May 25, 2023 Shannon Wilkinson was issued 250,000 common shares valued at $0 pursuant to the Company’s 2021 Equity Compensation Plan. As discussed further in note 10, the expense for shares issued is being recorded over the term of the performance units.

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Earl Johnson, Chief Financial Officer of the Company, for gross wages of $36,000 (June 30, 2022 - $5,455). At his separation date, the Company owed Mr. Johnson approximately $10,000 in gross wages The Company issued Mr. Johnson 100,000 shares of restricted common stock as part of a standard settlement and release agreement. 

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Chris White, a Director and Chief Information Security Officer of the Company, for management fees of $Nil (June 30, 2022 - $12,500) and gross wages of $20,000 (June 30, 2022 - $74,019). At his separation date, the Company owed Mr. White approximately $20,000 in gross wages. The Company issued Mr. White 100,000 shares of restricted common stock as part of a standard settlement and release agreement. 

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Troy Wilkinson, a Director of the Company, for management fees of $61,998 (June 30, 2022 - $62,500) and on May 25, 2023 Troy Wilkinson was issued 250,000 common shares valued at $0 pursuant to the Company’s 2021 Equity Compensation Plan. As discussed further in note 10, the expense for shares issued is being recorded over the term of the performance units

 

On May 25, 2023 Michael De Valera, a Director of the Company, was issued 100,000 common shares valued at $0 pursuant to the Company’s 2021 Equity Compensation Plan. As discussed further in note 10, the expense for shares issued is being recorded over the term of the performance units.

 

NOTE 9 – NOTES PAYABLE (convertible only at default)

 

 

(a)

On July 12, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $300,000 at $270,000 with a $30,000 original issue discount. In connection with this note, the Company paid an additional $27,500 in cash transaction costs, issued 350,000 common shares valued at $178,500 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. The warrants were calculated to have a fair value of $249,971 as at July 12, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On January 11, 2023, the Company and the lender agreed to extend the maturity date to July 12, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.

 

 
31

Table of Contents

 

 

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $102,943.

 

The Company also agreed to pay a commitment fee of $178,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 350,000 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $73,510.

 

As at June 30, 2023, the carrying value of this note payable was $299,926 (June 30, 2022 - $Nil) net of $74 unamortized discounts.

 

 

 

 

(b)

On July 15, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $89,250 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 15, 2027. The warrants were calculated to have a fair value of $124,984 as at July 15, 2022. This promissory note is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On January 11, 2023, the Company and the lender agreed to extend the maturity date to July 12, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $51,471.

 

 
32

Table of Contents

 

 

 

 

 

The Company also agreed to pay a commitment fee of $89,250 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $36,755.

 

As at June 30, 2023, the carrying value of this note payable was $149,963 (June 30, 2022 - $Nil) net of $37 unamortized discounts.

 

 

 

 

(c)

On July 18, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable e in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $89,250 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 18, 2027. The warrants were calculated to have a fair value of $124,994 as at July 18, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On January 11, 2023, the Company and the lender agreed to extend the maturity date to July 12, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $51,474.

 

The Company also agreed to pay a commitment fee of $89,250 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $36,755.

 

As at June 30, 2023, the carrying value of this note payable was $149,962 (June 30, 2022 - $Nil) net of $38 unamortized discounts.

 

 
33

Table of Contents

 

 

(d)

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with a $15,000 original issue discount. In connection with this note, the Company paid an additional $23,750 in cash transaction costs, issued 416,667 common shares valued at $187,625 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $220,526 as at October 13, 2022. This note payable matures on April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On April 12, 2023, the Company and the lender agreed to extend the maturity date to October 13, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 15% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $59,265.

 

The Company also agreed to pay a commitment fee of $187,625 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 416,667 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $50,423.

 

As at June 30, 2023, the carrying value of this note payable was $145,923 (June 30, 2022 - $Nil) net of $4,077 unamortized discounts.

 

 

 

 

(e)

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $67,500 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,333 common shares valued at $93,812 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $110,263 as at October 13, 2022. This promissory note matures on April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 
34

Table of Contents

 

 

 

 

 

On April 12, 2023, the Company and the lender agreed to extend the maturity date to October 13, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $29,633.

 

The Company also agreed to pay a commitment fee of $93,812 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 208,333 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $25,212.

 

As at June 30, 2023, the carrying value of this note payable was $72,960 (June 30, 2022 - $Nil) net of $2,040 unamortized discounts.

 

 

 

 

(f)

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $67,500 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,333 common shares valued at $93,812 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $110,263 as at October 13, 2022. This promissory note matures on April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On April 12, 2023, the Company and the lender agreed to extend the maturity date to October 13, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

 
35

Table of Contents

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $29,633.

 

The Company also agreed to pay a commitment fee of $93,812 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 208,333 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $25,212.

 

As at June 30, 2023, the carrying value of this note payable was $72,960 (June 30, 2022 - $Nil) net of $2,040 unamortized discounts.

 

NOTE 10 – COMMON SHARES

 

Common Stock

 

At June 30, 2023, the Company’s authorized capital consisted of 100,000,000 of common shares with a $0.001 par value and 47,343,282 shares were issued and outstanding.

 

During the year ended June 30, 2023, the Company incurred the following transactions:

 

On July 12, 2022, the Company issued 350,000 common shares at a relative fair value of $0.21 per share for transaction costs associated with the issuance of a note payable.

 

On July 15, 2022, the Company issued 175,000 common shares at a relative fair value of $0.21 per share for transaction costs associated with the issuance of a note payable.

 

On July 18, 2022, the Company issued 175,000 common shares at a relative fair value of $0.21 per share for transaction costs associated with the issuance of a note payable.

 

On July 26, 2022, the Company issued 275,000 common shares at a price of $0.51 (market price at the time of agreement) per share for marketing and branding services valued at $140,250.

 

On October 12, 2022, the Company issued 416,667 common shares at a relative fair value of $0.12 per share for transaction costs associated with the issuance of a note payable.

 

 

 
36

Table of Contents

 

On October 13, 2022, the Company issued 208,333 common shares at a relative fair value of $0.12 per share for transaction costs associated with the issuance of a note payable.

 

On October 13, 2022, the Company issued 208,333 common shares at a relative fair value of $0.12 per share for transaction costs associated with the issuance of a note payable.

 

On November 29, 2022, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On December 5, 2022, the Company completed a private placement whereby a total of 400,000 common shares were sold for cash at a price of $0.10 per share for a total value of $40,000.

 

On January 6, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 9, 2023, the Company issued 500,000 common shares at a price of $0.20 (market price at the time of agreement) to a non-related party in exchange for services.

 

On January 9, 2023, the Company issued 45,000 common shares at a price of $0.20 (market price at the time of agreement) per share to a non-related party in exchange for settlement of a debt.

 

On January 11, 2023, the Company completed a private placement whereby a total of 300,000 common shares were sold for cash at a price of $0.10 per share for a total value of $30,000.

 

On January 15, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.10 per share for a total value of $60,000.

 

On January 16, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 17, 2023, the Company completed various private placements whereby a total of 70,000 common shares were sold for cash at a price of $0.10 per share for a total value of $7,000.

 

On January 21, 2023, the Company completed various private placements whereby a total of 1,130,000 common shares were issued for cash at a price of $0.10 per share for a total value of $113,000.

 

On January 23, 2023, the Company completed various private placements whereby a total of 430,000 common shares were sold for cash at a price of $0.10 per share for a total value of $43,000.

 

On January 24, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000.

 

On January 25, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 28, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 30, 2023, the Company completed various private placements whereby a total of 850,000 common shares were sold for cash at a price of $0.10 per share for a total value of $85,000.

 

On February 6, 2023, the Company issued 1,000,000 common shares at a price of $0.18 (market price at the time of agreement) per share to a non-related party in exchange for services.

 

On February 6, 2023, the Company completed various private placements whereby a total of 225,000 common shares were sold for cash at a price of $0.10 per share for a total value of $22,500.

 

 

 
37

Table of Contents

 

On February 7, 2023, the Company completed various private placements whereby a total of 215,000 common shares were sold for cash at a price of $0.10 per share for a total value of $21,500.

 

On February 14, 2023, the Company completed various private placements whereby a total of 1,350,000 common shares were sold for cash at a price of $0.10 per share for a total value of $135,000.

 

On February 15, 2023, the Company completed a private placement whereby a total of 250,000 common shares were sold for cash at a price of $0.10 per share for a total value of $25,000.

 

On July 13, 2022, the Company entered into a securities purchase agreement with a non-related party in which the Company had issued a convertible debt in the principal amount of $300,000 at $270,000 cash with $30,000 original issue discount. In this agreement, the Company had issued 150,000 common shares and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. However, the Company and the non-related party have agreed and confirmed that certain Events of Default have occurred, including the Company’s failures to comply with its obligations and covenants with respect to: (i) failures to file registration statements and (ii) failures to comply with its obligations regarding the Subsequent Financings and the Purchaser’s rights thereto. As a result, on March 12, 2023, the Company and the non-related party have entered into a letter agreement in which the Company agreed to issue to the non-related party 2,233,333 restricted shares of the Company’s common stock at a price per share of $0.75 immediately upon the execution of the letter agreement as well as an additional 2,500,000 warrant shares exercisable at $0.25 per share. All other terms and conditions are to remain from the original agreement.

 

On March 23, 2023, the Company issued 2,000,000 common shares at a price of $0.78 (market price at the time of agreement) per share to a non-related party in exchange for services.

 

On March 24, 2023, the Company completed a private placement whereby a total of 750,000 common shares were sold for cash at a price of $0.10 per share for a total value of $75,000.

 

On April 4, 2023, the Company issued 100,000 common shares at a price of $1.04 (market price at the time of agreement) per share to a former employee as part of release and settlement agreement.

 

On April 10, 2023, the Company issued 100,000 common shares at a price of $0.85 (market price at the time of agreement) per share to a former consultant as part of release and settlement agreement.

 

On May 24, 2023, the Company completed a private placement whereby a total of 3,930,000 common shares were sold for cash at a price of $0.10 per share for a total value of $393,000.

 

On May 24, 2023, the Company completed a private placement whereby a total of 170,000 common shares were sold for cash at a price of $0.10 per share for a total value of $17,000.

 

On May 25, 2023, the Company issued 900,000 common shares to the directors and consultants from exercising their rights embedded with the performance stock units as they became exercisable. The expense was partially recorded in the current and prior years, at the time the performance stock units were granted.

 

On June 1, 2023, the Company issued 178,572 common shares at a price of $0.65 (market price at the time of agreement) per share to a non-related party in exchange for services.

 

On June 16, 2023, the Company completed a private placement whereby a total of 700,000 common shares were sold for cash at a price of $0.10 per share for a total value of $70,000.

 

During the year ended June 30, 2022, the Company incurred the following transactions:

 

During the period July 1, 2021 to October 28, 2021, the Company completed various private placements whereby a total of 5,558,810 common shares were issued for a total proceeds of $1,425,202.

 

On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for marketing services valued at $100,000.

 

 

 

 
38

Table of Contents

 

On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000.

 

On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for consulting services valued at $35,250.

 

On December 31, 2021, the Company issued 583,936 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $58,394. See Note 10 (a).

 

On December 31, 2021, the Company issued 353,215 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $35,321. See Note 10 (b).

 

On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for consulting services valued at $65,000.

 

On March 25, 2022, the Company issued 12,000 common shares to a non-related party at a price of $0.60 per share for a total value of $7,200 in exchange for services.

 

On May 19, 2022, the Company issued 400,000 common shares to a non-related party at a price of $0.577 per share for investor relations services valued at $230,800.

 

Warrants

 

On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $148,438 using the Black Scholes Option Pricing Model. These warrants expired during the three months ended March 31, 2023.

 

On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $399,087 using the Black Scholes Option Pricing Model.

 

On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $196,399 using the Black Scholes Option Pricing Model.

 

On July 12, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $249,971 using the Black Scholes Option Pricing Model and they were recorded at $102,943 in additional paid-in capital using the relative fair value method.

 

On July 15, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $124,984 using the Black Scholes Option Pricing Model and they were recorded at $51,471 in additional paid-in capital using the relative fair value method.

 

On July 18, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $124,994 using the Black Scholes Option Pricing Model and they were recorded at $51,474 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $220,526 using the Black Scholes Option Pricing Model and they were recorded at $59,265 in additional paid-in capital using the relative fair value method.

 

 

 
39

Table of Contents

 

On October 13, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $110,263 using the Black Scholes Option Pricing Model and they were recorded at $29,633 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $110,263 using the Black Scholes Option Pricing Model and they were recorded at $29,633 in additional paid-in capital using the relative fair value method.

 

On March 12, 2023, the Company granted 2,500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $1,847,450 using the Black Scholes Option Pricing Model.

 

The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants.

 

 

 

June 30,

2023

 

Stock price

 

$0.17 - $1.10

 

Risk-free interest rate

 

3.01% - 4.21

%

Expected life

 

5 Years

 

Expected dividend rate

 

 

0

 

Expected volatility

 

192.940% - 195.25

%

 

Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows:

 

 

 

Number

of

Warrants

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2021

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

4,500,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

(3,014,246 )

 

 

-

 

Outstanding, June 30, 2023

 

 

4,500,000

 

 

$0.25

 

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted Average

Life (Years)

 

 

Expiry

Date

 

July 12, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

 

0.45

 

 

July 12, 2027

 

July 15, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.22

 

 

July 15, 2027

 

July 18, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.23

 

 

July 18, 2027

 

October 13, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

 

0.48

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.24

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.24

 

 

October 13, 2027

 

March 12, 2023

 

 

2,500,000

 

 

 

2,500,000

 

 

 

0.25

 

 

 

2.61

 

 

March 12, 2028

 

Total

 

 

4,500,000

 

 

 

4,500,000

 

 

 

0.25

 

 

 

4.46

 

 

 

 

 

As of June 30, 2023, the weighted average remaining contractual life of warrants outstanding was 4.46 years with an intrinsic value of $0.

 

 

 
40

Table of Contents

 

Stock Options

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

During the year ended June 30, 2023 the Company issued a total of 6,000,000 non-qualified stock options (the “options”) to directors, officers and certain key consultants. The options are subject to the terms and conditions of the Equity Compensation Plan. All granted options are subject to a five-year vesting schedule equal to 20% per year starting on the 1st day of each year following the effective date. All options have an exercise price of $0.65 which was the closing price of the Company’s common stock on the day the day grant.

 

The following is a continuity schedule for the Company’s outstanding non-qualified stock options:

 

 

 

Number of

options

 

 

Weighted Average

Exercise

Price

 

Outstanding, June 30, 2021

 

 

-

 

 $

 

 Granted

 

 

 6,000,000

 

 

 0.65

 

 Exercised

 

 

 -

 

 

-

 

 Cancelled

 

 

 -

 

 

 -

 

Outstanding, June 30, 2022

 

 

 6,000,000

 

 $

0.65

 

Granted

 

 

125,000

 

 

 0.65

 

Exercised

 

 

-

 

 

-

 

Cancelled

 

 

(125,000)

 

0.65

 

Outstanding, June 30, 2023

 

 

6,000,000

 

 $

 0.65

 

 

As at June 30, 2023, the Company had the following stock options outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted Average Life (Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

25,000

 

 

0.65

 

 

8.52

 

 

January 3, 2032

 

January 4, 2022

 

 

5,750,000

 

 

 

1,150,000

 

 

0.65

 

 

8.52

 

 

January 4, 2032

 

March 1, 2023

 

 

125,000

 

 

 

25,000

 

 

0.65

 

 

8.52

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

1,200,000

 

 

0.65

 

 

8.52

 

 

 

 

 

During the year ended June 30, 2023, the Company recorded $1,070,990 as share-based compensation relating to the issuance of the non-qualified stock options with an intrinsic value of $0.

 

The fair value of the options granted during the year ended June 30, 2023 was estimated on the date of the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Expected volatility

 

187.07

%

Expected option life (years)

 

6 years

 

Risk-free interest rate (10-year U.S. treasury yield)

 

4.22

%

Expected dividend yield

 

 

0%

 

Performance Stock Units

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

 

 
41

Table of Contents

 

During the year ended June 30, 2022 the Company issued a total of 4,000,000 performance stock units (“performance units”) to directors, officers and certain key consultants. The performance units are subject to the terms and conditions of the Equity Compensation Plan. The performance units will be earned and vest upon reaching certain market capitalization goals during the performance period ending on December 31, 2026.

 

Each unit represents one common share:

 

Number of Performance Units

 

 

Vesting Conditions

 

Expiry Dates

 

-

 

 

Market capitalization of the Company reaches $25 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $50 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $75 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $100 million

 

December 31, 2026

 

On March 20, 2023, the Company terminated its employment relationship with one of the unit holders who had 400,000 performance stock units where the rights had been cancelled.

 

During the year ended June 30, 2023, the Company’s market capitalization reached over $25 million and the unit holders exercised 900,000 options in exchange for 900,000 common shares. Intrinsic value varies for each vesting condition based on stock price at the time. None of the outstanding units are exercisable as of June 30, 2023.

 

The following is a continuity schedule for the Company’s outstanding performance stock units:

 

 

 

Number of

Performance Units

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

(900,000)

 

 

-

 

Forfeited or cancelled

 

 

(400,000)

 

 

-

 

Outstanding, June 30, 2022

 

 

2,700,000

 

 

$-

 

 

As of June 30, 2022, the Company had the following performance units outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted

Average Life

(Years)

 

 

Expiry

Date

 

March 8, 2022

 

 

2,700,000

 

 

 

-

 

 

USD $0.00

 

 

3.51

 

 

December 31, 2026

 

Total

 

 

2,700,000

 

 

 

-

 

 

USD $0.00

 

 

3.51

 

 

 

 

 

During the year ended June 30, 2023, the Company recorded $475,453 as share-based compensation relating to the issuance of the performance units. $775,301 has been recorded as share-based compensation relating to the outstanding performance units to date. The remaining $124,699 will be recorded as share-based compensation over the remaining life of the units.

 

No performance units were granted during the year ended June 30, 2023.The fair value of the performance units granted during the year ended June 30, 2022 was estimated on the date of the grant date using output from a Black-Sholes model to calculate the value of the award multiplying by the current stock price as of the valuation date with the following weighted average assumptions:

 

Expected volatility

 

 

85.0%

Requisite period

 

4.00 years

 

Risk-free interest rate (US Treasury Bond rate as of the grant date)

 

 

1.80%

Expected dividend yield

 

 

0%

 

 

 
42

Table of Contents

 

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

 

NOTE 12 – INCOME TAXES

 

As of June 30, 2023, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax.

 

Net operating loss carry forward of the Company, amounted to $6,818,462 (June 30, 2022 - $2,909,935) for the year ended June 30, 2023. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2043. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.

 

NOTE 13 – RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are limited to the Balance Sheet and Statement of Operations and have no effect on the reported results of operations.

 

NOTE 14 – SUBSEQUENT EVENTS

 

On July 3, 2023, the Company granted 1,250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $710,118 using the Black Scholes Option Pricing Model.

 

With reference to the Side Letter received on July 3, 2023 from the above lender, the Company agreed to issue 1,116,667 common shares at a price per share of $0.10 (the “Additional Commitment Fee Shares”) as consideration specified in the purchase agreements.

 

With regards to the securities purchase agreement entered on July 15, 2022 with above lender, the Company and the lender agreed to increase the principal amount of the note by $15,000, which amount would bear interest as set forth in the July 2022 Note and extend the maturity date to August 14, 2023.

 

On July 3, 2023, the Company granted 1,250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to another lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $710,118 using the Black Scholes Option Pricing Model.

 

With reference to the Side Letter received on July 3, 2023 from the above lender, the Company agreed to issue 1,116,667 common shares at a price per share of $0.10 as consideration specified in the purchase agreements.

 

With regards to the securities purchase agreement entered on July 15, 2022 with above lender, the Company and the lender agreed to increase the principal amount of the note by $15,000, which amount would bear interest as set forth in the July 2022 Note and extend the maturity date to August 14, 2023.

 

On July 3, 2023, the Company issued 100,000 common shares at a price of $0.65 per share to members of the newly appointed advisory board.

 

 

 
43

Table of Contents

 

On July 3, 2023, the Company issued 250,000 common shares at a price of $0.48 per share to non-related parties in exchange for services.

 

On July 27, 2023, the Company completed a private placement whereby a total of 500,000 common shares were sold for cash at a price of $0.10 per share for a total value of $50,000.

 

On August 17, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On August 21, 2023, the Company issued 800,000 common shares at a price of $0.10 per share as consideration for extension of the maturity date related to a note payable financing transaction (Note 9).

 

On August 22, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.15 per share for a total value of $90,000.

 

On September 1, 2023, the Company made a $50,000 payment on an outstanding note payable financing transaction (Note 9).

 

On September 15, 2023, the Company issued 100,000 common shares at a price of $0.2328 per share to the former Chief Financial Officer pursuant to a Separation Agreement and Release.

 

On September 15, 2023, the Company issued 250,000 common shares at a price of $0.2328 per share to its newly appointed Chief Financial Officer pursuant to a Consulting Agreement.

 

On September 19, 2023, the Company issued 500,000 common shares at a price of $0.22 per share to a non-related party in exchange for services.

 

On September 20, 2023, the Company received a purchase order for a license fee for its threat correlation application for integration with Splunk.

 

On October 6, 2023, the Company issued 1,000,000 common shares at a price of $0.10 per share as consideration for extension of the maturity date related to a note payable financing transaction (Note 9).

 

 

44

Table of Contents

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

On April 10, 2023, we received notice of resignation from BF Borgers CPA PC (“BF Borgers”), as our registered independent registered public accountant. We appointed M&K CPAS, PLLC (“M&K”) as our registered independent public accounting firm on May 10, 2023. The decision to appoint M&Ks was approved by our Board of Directors on May 10, 2023.

 

Disagreements with Accountants on Accounting and Financial Disclosure

 

Borgers' report on the financial statements of the Company for the year ended June 30, 2022 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles, with the exception of the emphasis of a matter raising substantial doubt about its ability to continue as a going concern.

 

During the year ended June 30, 2022 and subsequent interim periods from July 1, 2022 to April 10, 2023, there were (i) no disagreements on any matter of accounting principles or practices, financial statement disclosures, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would have caused them to make reference to the subject matter of the disagreements in connection with its reports on the Company's financial statements for such periods, and (ii) no “reportable events” within the meaning of Item 304(a)(1)(v) of Regulation S-K , other than as noted above regarding the Company’s ability to continue as a going concern and except for the material weaknesses identified related to (i) lack of an audit committee and financial expert, and (ii) limited personnel to assist with the accounting and financial reporting function resulting in (a) a lack of segregation of duties and (b) controls that may not be adequately designed or operating effectively.

 

During the two most recent fiscal years and in the subsequent interim period through May 10, 2023, the Company did not consult with M&K regarding (1) the application of accounting principles to specified transactions, either completed or proposed, (2) the type of audit opinion that might be rendered on the Company’s financial statements, (3) written or oral advice was provided that would be an important factor considered by the Company in reaching a decision as to an accounting, auditing or financial reporting issues, or (4) any matter that was the subject of a disagreement between the Company and its predecessor auditor as described in Item 304(a)(1)(iv) or a reportable event as described in Item 304(a)(1)(v) of Regulation S-K.

 

Item 9.A Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We conducted an evaluation, under the supervision and with the participation of our management, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive and principal financial officers concluded as of June 30, 2023 that our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses in our internal controls over financial reporting discussed immediately below.

 

Identified Material Weakness

 

A material weakness in our internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting, which are primarily due to the size of the Company and available resources:

 

Personnel: We do not employ a full-time Chief Financial Officer. We utilize a consultant to assist with our financial reporting. There are limited personnel to assist with the accounting and financial reporting function, which results in: (i) a lack of segregation of duties and (ii) controls that may not be adequately designed or operating effectively. Despite the existence of material weaknesses, the Company believes the financial information presented herein is materially correct and fairly presents the financial position and operating results of the years ended June 30, 2023 and 2022, in accordance with GAAP. During 2022-2023, the Company intends to seek qualified accounting staff to expand its internal accounting and reporting functions.

 

Audit Committee: We do not yet have an audit committee, and we lack a financial expert. During 2022-2023, the Board expects to appoint an Audit Committee and to identify a committee Chairman who is an “audit committee financial expert” as defined by the Securities and Exchange Commission (“SEC”) and as adopted under the Sarbanes-Oxley Act of 2002.

 

 
45

Table of Contents

 

Management's Report on Internal Control Over Financial Reporting.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is a process designed by, or under the supervision of, our CEO and CFO, or persons performing similar functions, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (GAAP). Our internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and disposition of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP and that receipts and expenditures of the Company are being made only in accordance with authorization of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Management assessed the effectiveness of the Company’s internal control over financial reporting as of June 30, 2023. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control-Integrated Framework. Based on its evaluation, management has concluded that the Company’s internal control over financial reporting was not effective as of June 30, 2023.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A control system, no matter how well designed and operated, can provide only reasonable, but not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their cost.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting subsequent to the fiscal year ended June 30, 2023, which were identified in connection with our management’s evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

We are not required by current SEC rules to include an auditor's attestation report. Our registered public accounting firm has not attested to Management's reports on our internal control over financial reporting.

 

Limitations of the Effectiveness of Disclosure Controls and Internal Controls

 

Our management, including our Principal Executive Officer and Principal Financial Officer, does not expect that our disclosure controls and internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control.

 

The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

  

Item 9.B Other Information

 

During the fiscal year ended June 30, 2023, we completed various private placements whereby a total of 12,970,000 common shares were issued for a total of $1,297,000 cash. We also issued 3,953,572 common shares for services valued at $2,096,304. We also issued 45,000 common shares in settlement of convertible debt valued at $9,000.

 

Item 9.C Disclosure Regarding Foreign Jurisdiction the Prevent Inspection

 

Not applicable. 

 

 
46

Table of Contents

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Identification of Directors and Executive Officers

 

The following table sets forth the names and ages of our current directors and executive officers as of January 17, 2024:

 

Name and Age

 

Position(s) Held

 

Date of Appointment

 

Other Public Company

Directorships

Shannon Wilkinson, 46

 

Director, President, Chief    Executive Officer

 

September 6, 2019

 

None

Robert Mikkelsen, 42

 

Chief Financial Officer

 

September 15, 2023

 

None

Troy Wilkinson, 47

 

Director

 

September 6, 2019

 

None 

Michael De Valera, 58

 

Director

 

September 6, 2019

 

None

Chris White, 52

 

Director

 

April 14, 2021

 

None

 

Term of Office

 

Should a vacancy exist, our Board of Directors has the power to nominate and appoint a director or directors to fill such vacancy, and each shall hold office until the next annual meeting of stockholders and until his/her successor shall have been duly elected and qualified.

 

Background and Business Experience

 

Shannon Wilkinson – Director, President, Chief Executive Officer, Secretary and Treasurer

 

Shannon Wilkinson is a graduate from the University of Nevada, Las Vegas with a Bachelor's in Management Information Systems. She also earned her Master’s in Information Systems Management from the University of Phoenix. Shannon spent the first 12 years of her career overseas working for the United Nations Department of Peacekeeping Operations building mission critical software platforms. Upon her return to the US in February 2013, Shannon joined SocialWellth as Director of Software Development leading development teams in building software platforms for some of the largest healthcare organizations. She remained in that position until summer of 2015 when she left to co-found Axiom Cyber Solutions where she was responsible for the software development arm of the company, developing Axiom’s cloud based Polymorphic Cyber Defense Platform. She exited Axiom Cyber Solutions in June 2019 when Axiom was acquired by a private equity firm. In September 2019, Mrs. Wilkinson co-founded Tego Cyber Inc. with her husband, with a mission to develop an innovative threat intelligence platform and continue developing automated cybersecurity solutions to help companies respond to the ever-changing cyber threat landscape. Mrs. Wilkinson works full time in her capacity as Director, President, CEO, Secretary and Treasurer of Tego Cyber Inc. Mrs. Wilkinson was selected as the 2018 Las Vegas Women in Technology - Cybersecurity, 2017 Las Vegas Women in Technology Entrepreneur as well as appeared in the MyVEGAS Magazine Top 100 Women of Las Vegas in 2017 and 2018.

 

 
47

Table of Contents

 

Robert Mikkelsen – Chief Financial Officer

 

Robet Mikkelsen has been instrumental in developing accounting systems and controls for complex organizations, corporate development, mergers and acquisitions, and fundraising, with total transactions valued over $100 million. Mr. Mikkelsen received his bachelor’s degree in accounting in 2004 from the Eller College of Business, University of Arizona. After graduating, Mr. Mikkelsen went on to work as an auditor for Henry & Horne, LLP in Arizona. Mr. Mikkelsen’s career in public accounting included working with a client base which was diverse in size and sector, revenue ranging from $100 thousand to $1 billion annually including those in the health care, pharmaceutical and tech sectors. Mr. Mikkelsen has also served as the Chief Financial Officer for Item Nine Labs Corp (“INLB”) since October 2018.

 

Troy Wilkinson – Director

 

Troy Wilkinson began his career in January 2000 as a Law Enforcement officer with the Conway Police Department where he remained until June 2007 when he joined a Joint Terrorism Task Force as a lead bomb investigator and violent crime homicide detective. In December 2008 Troy was recruited by the U.S. State Department to train police officers in Kosovo on cybercrime related matters where he earned a reputation as a top cybercrime investigator. Together with a team of international investigators he built the first IT forensics lab in the European Union Mission in Kosovo. After returning home to the U.S. in February 2013, Mr. Wilkinson joined SocialWellth as its Infrastructure Security Director. He remained in that position until June 2014 when he accepted the position of Director of Information Technology for Litigation Services, LLC. In the summer of 2015, he co-founded Axiom Cyber Solutions with his wife Shannon Wilkinson and left in December of 2018 to accept the position of Executive Director of Information Security (CISO) with International Cruise and Excursion where he remained until August 2019. In addition to his role as Director of Tego Cyber Inc., Mr. Wilkinson is currently is the Chief Information Security Officer for Interpublic Group of Companies (IPG) where he is responsible for all aspects of cyber defense for over 60,000 users in more than 130 countries. Mr. Wilkinson is a worldwide keynote speaker on cybersecurity, co-authored an Amazon Best Seller, is featured on several news sources as a cybersecurity expert and has contributed to numerous national syndicated publications on cybersecurity topics including ransomware, DDoS, cyber-crime trends, and cyber security careers.

 

Michael De Valera – Director

 

Michael De Valera has over thirty years of experience providing information technology services. In 1989 he co-founded Internet Computers, Inc. where he remained as one of the founding principles until January 2006 when he left to start his own company TechnoMedia Consulting, Inc. where he remains the sole principal to this day. TechnoMedia Consulting, Inc. provides information technology services for companies and organizations that are either too small to have their own dedicated IT departments or simply realize that specialized functionality is more efficiently and economically provided by a third party. His clients cover a broad range of organizations and industries. His undergraduate BA Finance studies, majoring in Finance and Economics, were at the University of Pennsylvania Wharton School of Finance. Michael currently dedicates up to 5 hours a week to Tego Cyber Inc. and will allocate more time when first product is launched.Michael has traveled extensively around the world and his personal interests include wine and cooking.

 

Chris White – Director

 

Chris White has over thirty years of experience in cyber security, telecommunications and automation. He most recently was the Deputy CISO / Director of Global Security Operations for The Interpublic Group of Companies, Inc. and has previously served as the Chief Technology Officer for EY MSS, Senior Security Engineer at AT&T, Senior Lead Engineer at General Dynamics AIS, and a member of the US Air Force. He holds a master's degree in Systems Engineering and a Bachelor of Science degree in Network Engineering from Regis University.

 

Term of Office

 

Each director serves for a term of one year and until his successor is elected at the Annual Shareholders’ Meeting and is qualified, subject to removal by the shareholders. Each officer serves for a term of one year and until his successor is elected at a meeting of the Board of Directors and is qualified. Each member of the Advisory Board serves at the discretion of the Board of Directors.

 

 
48

Table of Contents

 

Employees

 

We have a total of 5 employees, 2 of which are our executive officers. We currently employ 5 full-time employees and 2 part-time employees. These individuals are not obligated to devote any specific number of hours to our matters and intend to devote only as much time as they deem necessary to our affairs. At this time, our President and Chief Executive Officer is devoted full time to our operations and devotes approximately 40-50 hours per week. At this time, our Chief Financial Officer devotes approximately 10-15 hours per week to our operations. The amount of time they will devote in any time period will vary based on the stage of our business and the progress we make. Accordingly, once we are beyond the developmental phase our management will spend more time on our affairs. Additionally, we have 12 contracted consultants.

 

Limitation of Liability and Indemnification Matters

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.

 

Identification of Significant Employees

 

We have no significant employees other than the aforementioned Officers and Directors.

 

Family Relationship

 

Shannon and Troy Wilkinson are husband and wife. Other than the foregoing, we currently do not have any officers or directors of who are related to each other.

 

Involvement in Certain Legal Proceedings

 

During the past ten years no director, executive officer, promoter or control person of our company has been involved in the following:

 

 

(1)

a petition under the Federal bankruptcy laws or any state insolvency law which was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

 

 

 

 

(2)

such person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

 

 

 

(3)

such person was the subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities:

 

 

i.

Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

 

 

 

 

ii.

Engaging in any type of business practice; or

 

 

 

 

iii.

Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws;

 

 
49

Table of Contents

 

 

(4)

such person was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph (f)(3)(i) of this section, or to be associated with persons engaged in any such activity;

 

 

 

 

(5)

such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

 

 

 

(6)

such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

 

 

 

 

(7)

such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

 

 

i.

Any Federal or State securities or commodities law or regulation; or

 

 

 

 

ii.

Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or

 

 

 

 

iii.

Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

 

(8)

such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Independence of Directors

 

The Board of Directors is currently composed of 4 members. Mrs. Shannon Wilkinson, Mr. Troy Wilkinson, Mr. Michael De Valera and Mr. Chris White. Mrs. Wilkinson and Mr. White do not qualify as an independent Directors in accordance with the published listing requirements of the NASDAQ Global Market as they hold officer positions. Mr. Wilkinson does not qualify as an independent Directors in accordance with the published listing requirements of the NASDAQ Global Market as he is married to Mrs. Wilkinson. Mr. Michael De Valera does qualify as independent director as he is not an officer of our company. The NASDAQ independence definition includes a series of objective tests, such as that the Director is not, and has not been for at least three years, one of the company’s employees and that neither the Director, nor any of his family members has engaged in various types of business dealings with us. In addition, the Board of Directors has not made a subjective determination as to each Director that no relationships exist which, in the opinion of the Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a Director, though such subjective determination is required by the NASDAQ rules. Had the Board of Directors made these determinations, the Board of Directors would have reviewed and discussed information provided by the Directors and the Company with regard to each Director’s business and personal activities and relationships as they may relate to the Company and its management.

 

Committees

 

We do not currently have an audit, compensation or nominating committee. The Board of Directors as a whole currently acts as our audit, compensation and nominating committees. We intend to establish an audit, compensation and nominating committee of our Board of Directors once we expand the Board to include one or more independent directors and intend to adopt a charter for each committee.

 

 
50

Table of Contents

 

Our audit committee shall be primarily responsible for reviewing the services performed by our independent auditors, evaluating our accounting policies and our system of internal controls. Our compensation committee shall assist the Board in reviewing and approving the compensation structure, including all forms of compensation, relating to our directors and executive officers and periodically reviewing and approving any long-term incentive compensation or equity plans, programs or similar arrangements. Our nominating committee shall assist the Board in selecting individuals qualified to become our directors and in determining the composition of the Board and its committees.

 

Compliance with Section 16(a) of the Exchange Act

 

Section 16(a) of the Exchange Act requires the Company’s directors, executive officers and persons who beneficially own 10% or more of a class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in beneficial ownership with the SEC. Directors, executive officers and greater than 10% stockholders are required by the rules and regulations of the SEC to furnish the Company with copies of all reports filed by them in compliance with Section 16(a). To the Company’s knowledge, based solely on a review of reports furnished to it, for the year ended June 30, 2023, all of the Company’s officers, directors and ten percent holders have made the required filings, except: Christopher White filed a Form 4 on April 13, 2023, which was delinquent, in connection with his departure as Chief Information Security Officer; Earl Johnson’s delinquent Form 3 in connection with his becoming an executive officer of the Company in May 2022.

 

Risk Oversight

 

Effective risk oversight is an important priority of the Board of Directors. Because risks are considered in virtually every business decision, the Board of Directors discusses risk throughout the year generally or in connection with specific proposed actions. The Board of Directors’ approach to risk oversight includes understanding the critical risks in our business and strategy, evaluating our risk management processes, allocating responsibilities for risk oversight among the full Board of Directors, and fostering an appropriate culture of integrity and compliance with legal responsibilities.

 

Corporate Governance

 

We promote accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in other public communications made; and we strive to be compliant with applicable governmental laws, rules and regulations. We have not yet formally adopted a written code of business conduct and ethics that govern our employees, officers and Directors as we are not currently required to do so.

 

In lieu of an Audit Committee, our Board of Directors is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of our financial statements and other services provided by our independent public accountants. The Board of Directors reviews our internal accounting controls, practices and policies.

 

Code of Ethics

 

Our Board of Directors has not adopted a code of ethics. We anticipate that we will adopt a code of ethics when we increase either the number of our Directors or the number of our employees.

 

 
51

Table of Contents

 

Item 11. Executive Compensation

 

The following table sets forth for the years ended June 30, 2023 and 2022, information with respect to compensation earned for services in all capacities to us by the Company’s Chief Executive Officer and the Company’s Chief Financial Officer. The table sets forth for the years ended June 30, 2023 and 2022, information with respect to compensation for services in all capacities to us earned by the one other most highly compensated executive officer who received total compensation in excess of $100,000. No other executive officers received total annual salary and bonus compensation in excess of $100,000.

 

Name Position

 

Fiscal Year

Ended 6/30

 

Wages

$

 

 

Management

Fees

$

 

 

Performance

Stock Units

Vested

$

 

 

All Other

Compensation

$

 

 

Total

$

 

Shannon Wilkinson (1)

 

2023

 

 

122,500

 

 

 

-

 

 

 

162,500

 

 

 

-

 

 

 

285,000

 

Earl Johnson (5)

 

2023

 

 

36,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

36,000

 

Chris White (4)

 

2023

 

 

20,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20,000

 

Troy Wilkinson (2)

 

2023

 

 

-

 

 

 

61,998

 

 

 

162,500

 

 

 

-

 

 

 

224,498

 

Michael De Valera (3)

 

2023

 

 

-

 

 

 

-

 

 

 

65,000

 

 

 

-

 

 

 

65,000

 

 

 

 

 

 

178,500

 

 

 

61,998

 

 

 

390,000

 

 

 

-

 

 

 

630,498

 

 

Narrative Disclosure to Summary Compensation Table

 

(1)

On January 3, 2022, the Company entered into an employment agreement with Shannon Wilkinson (the “Wilkinson Employment Agreement”) having an effective date of January 1, 2022. The Wilkinson Employment Agreement provides for 5 year initial term. Thereafter, either the Company or Ms. Wilkinson has the right to extend the Wilkinson Employment Agreement for 3 additional one-year terms. The Company and Ms. Wilkinson can mutually elect to terminate the Wilkinson Employment Agreement at any time upon 90 days written notice. Ms. Wilkinson is entitled to a base salary of $120,000 per year. Ms. Wilkinson has been granted non-qualified options to purchase 2,000,000 shares under the terms and conditions of the Company’s 2021 Equity Compensation Plan (“Equity Compensation Plan”). The stock options shall be subject to a 5 year vesting schedule of 400,000 options on the 1st day of each year following the Effective Date. The option grant is priced at $0.65 per share. The Company has also granted to Mrs. Wilkinson, performance stock units of 1,000,000 shares of the Company’s common stock pursuant to the Equity Compensation Plan which shall vest in 250,000 share increments upon reaching certain market capitalization goals. On May 25, 2023 Mrs. Wilkinson was issued 250,000 common shares valued at $162,500 pursuant to Equity Compensation Plan. In the event Mrs. Wilkinson’s employment is terminated without Cause or Mrs. Wilkinson resigns for Good Reason (as Cause and Good Reason are defined in the Wilkinson Employment Agreement) within 12 months of a Change in Control (as defined in the Wilkinson Employment Agreement), Mrs. Wilkinson shall receive her salary for the duration of the term of the Wilkinson Employment Agreement and 100% of the total number of Options and Performance stock units due to Mrs. Wilkinson for the duration of the term of the Wilkinson Employment Agreement shall immediately become vested and issuable.

 

 

(2)

 

There is no formal contract in place for Troy Wilkinson to act as director. Mr. Wilkinson has been granted non-qualified options to purchase 2,000,000 common shares under the terms and conditions of the Company’s 2021 Equity Compensation Plan. The stock options shall be subject to a 5 year vesting schedule of 400,000 options on the 1st day of each year following the Effective Date. The option grant is priced at $0.65 per share. The Company has also granted to Mr. Wilkinson performance stock units of 1,000,000 shares of the Company’s common stock pursuant to the Equity Compensation Plan which shall vest in 250,000 share increments upon reaching certain market capitalization goals. On May 25, 2023, Mr. Wilkinson was issued 250,000 common shares valued at $162,500 pursuant to Equity Compensation Plan

 

(3)

There is no formal contract in place for Michael De Valera to act as director. Mr. De Valera has been granted non-qualified options to purchase 125,000 common shares under the terms and conditions of the Company’s 2021 Equity Compensation Plan. The stock options shall be subject to a 5 year vesting schedule of 25,000 options on the 1st day of each year following the Effective Date. The option grant is priced at $0.65 per share. The Company has also granted Mr. De Valera performance stock units of 400,000 shares of the Company’s common stock pursuant to the Equity Compensation Plan which shall vest in 100,000 share increments upon reaching certain market capitalization goals. On May 25, 2023, Mr. De Valera was issued 250,000 common shares valued at $65,000 pursuant to Equity Compensation Plan

 

 

(4)

On March 20, 2023, the Board accepted the resignation of Mr. Chris White as Chief Information Security Officer (“CISO”), effective March 1, 2023. Mr. White will remain serving as a member of the Board. In connection with Mr. White’s resignation as CISO, the Company and Mr. White entered into a Separation Agreement and Release  dated as of March 20, 2023, pursuant to which Mr. White agreed to accept a lump sum payment of 100,000 restricted common shares of the Company stock in lieu of all and any amounts owing including (if applicable) backpay, vacation pay and severance and he  has also agreed to forfeit any right to exercise any portion of the non-qualified stock options granted to him subject to the terms of the Equity Compensation Plan. Mr. White has also agreed to forfeit any right to exercise any portion of the performance stock units granted to him subject to the terms of the Equity Compensation Plan.

 

 

(5)

Mr. Johnson served as CFO from April 26, 2022 until his resignation effective September 15, 2023. The Company and Mr. Johnson entered into a Separation Agreement and Release dated as of September 15, 2023, pursuant to which Mr. Johnson have agreed upon certain terms related to his separation. Mr. Johnson has agreed to accept a lump sum payment of (i) $1,500 payable prior to September 30, 2023 and  (ii) 100,000 restricted common shares of the Company stock in lieu of all and any amounts owing.

 

 
52

Table of Contents

 

Outstanding Equity Awards at Fiscal Year-End

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

Stock Options

 

During the year ended June 30, 2022, the Company issued a total of 6,000,000 non-qualified stock options (the “options”) to directors, officers and certain key consultants. The options are subject to the terms and conditions of the Equity Compensation Plan.  All granted options are subject to a five-year vesting schedule equal to 20% per year starting on the 1st day of each year following the effective date. All options have an exercise price of $0.65 which was the closing price of the Company’s common stock on the day the day grant. As of June 30, 2023, 1,200,000 of the options had vested but not yet exercised.

 

The following is a continuity schedule for the Company’s outstanding non-qualified stock options:

 

 

 

Number of

Options

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

6,000,000

 

 

$0.65

 

Granted

 

 

125,000

 

 

 

0.65

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

125,000

 

 

 

0.65

 

Outstanding, June 30, 2023

 

 

6,000,000

 

 

$0.65

 

 

As at June 30, 2023, the Company had the following stock options outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted Average

Life (Years)

 

 

Expiry

Date

 

January 3, 2022

 

 

125,000

 

 

 

25,000

 

 

$0.65

 

 

 

8.52

 

 

January 3, 2032

 

January 4, 2022

 

 

5,750,000

 

 

 

1,150,000

 

 

$0.65

 

 

 

8.52

 

 

January 4, 2032

 

March 1, 2023

 

 

125,000

 

 

 

25,000

 

 

$0.65

 

 

 

8.52

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

1,200,000

 

 

$0.65

 

 

 

8.52

 

 

 

 

 

 
53

Table of Contents

 

Performance Stock Units

 

During the year ended June 30, 2023, the Company issued a total of 4,000,000 performance stock units (“performance units”) to directors, officers and certain key consultants. The performance units are subject to the terms and conditions of the Equity Compensation Plan. The performance units will be earned and vest upon reaching certain market capitalization goals during the performance period ending on December 31, 2026. As of June 30, 2023, 900,000 of the performance stock units had vested and were exercised.

 

The following is a continuity schedule for the Company’s outstanding performance stock units: 

 

 

 

Number of

Units

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

-

 

 

$-

 

Granted

 

 

4,000,000

 

 

 

-

 

Exercised

 

 

(900,000)

 

 

-

 

Cancelled

 

 

(400,000)

 

 

-

 

Outstanding, June 30, 2023

 

 

2,700,000

 

 

$-

 

 

As at June 30, 2023, the Company had the following performance stock units outstanding:

 

 Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted Average

Life (Years)

 

 

Expiry

Date

 

March 8, 2022

 

 

2,700,000

 

 

 

2,700,000

 

 

$-

 

 

 

3.51

 

 

December 31, 2026

 

Total

 

 

2,700,000

 

 

 

2,700,000

 

 

$-

 

 

 

3.51

 

 

 

 

 

Long-Term Incentive Plans

 

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers.

 

Compensation of Directors

 

Our directors receive no annual salary or bonus for their service as members of the Company’s board of directors.

 

Security Holders Recommendations to Board of Directors

 

Shareholders can direct communications to our Chief Executive Officer, Shannon Wilkinson, at our executive offices. However, while we appreciate all comments from shareholders, we may not be able to individually respond to all communications. We attempt to address shareholder questions and concerns in our press releases and documents filed with the SEC so that all shareholders have access to information about us at the same time. Mrs. Wilkinson collects and evaluates all shareholder communications. All communications addressed to our directors and executive officers will be reviewed by those parties unless the communication is clearly frivolous.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters

 

The following table sets forth certain information concerning the number of shares of our common stock owned beneficially as of January 17, 2024, by: (i) each of our directors; (ii) each of our named executive officers; and (iii) each person or group known by us to beneficially own more than 5% of our outstanding shares of common stock. Unless otherwise indicated, the shareholders listed below possess sole voting and investment power with respect to the shares they own. 

 

 
54

Table of Contents

 

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

 

Name and Address of Beneficial Owner

 

Amount and Nature

of Beneficial

Ownership (1)

(#)

 

 

Percent of

Class (1)

(%)

 

AJB Capital Investments LLC (2)

 

 

4,461,703

 

 

 

8.30%

Shannon Wilkinson (3)

 

 

3,250,000

 

 

 

6.04%

Troy Wilkinson (4)

 

 

3,250,000

 

 

 

6.04%

Michael De Valera (5)

 

 

1,120,000

 

 

 

2.08%

Robert Mikkelsen (6)

 

 

250,000

 

 

 

0.46%

Chris White (7)

 

 

208,000

 

 

 

0.40%

All Officers, Directors and Beneficial Owners as a Group Total

 

 

12,539,703

 

 

 

23.32%

 

(1) The number and percentage of shares beneficially owned is determined under rules of the SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares, which the individual has the right to acquire within 60 days through the exercise of any stock option or other right. The persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and the information contained in the footnotes to this table.

 

Based on 53,776,616 issued and outstanding shares of common stock as of January 17, 2024.

 

(2) AJB Capital Investments LLC is controlled by AJB Capital Managers LLC, in its capacity as the Manager of AJB Investments, and has the ability to direct the management of the business. The address for AJB Capital Investments LLC is 4700 Sheridan Street, Suite J, Hollywood, FL 33031.

 

(3) Shannon Wilkinson is a Director and the Company's Chief Executive Officer and President. Her beneficial ownership includes 3,250,000 common shares.

 

(4) Troy Wilkinson is a Director of the Company. His beneficial ownership includes 3,250,000 common shares.

 

(5) Michael De Valera is a Director of the Company. His beneficial ownership includes 1,120,000 common shares directly owned.

 

(6) Robert Mikkelsen is the Chief Financial Officer of the Company. His beneficial ownership includes 250,000 common shares directly owned.

 

(7) Chris White is a Director of the Company and the Company’s former Chief Information Security Officer. His beneficial ownership includes 208,000 common shares directly owned.

 

Changes in Control

 

There are no present arrangements or pledges of the Company’s securities, which may result in a change in control of the Company.

 

 
55

Table of Contents

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

Related Party Transactions

 

Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Shannon Wilkinson, a Director, CEO, President, Secretary and Treasurer of the Company, for management fees of $Nil (June 30, 2022 - $101,750), gross wages of $122,500 (June 30, 2022 - $98,692) and on May 25, 2023 Shannon Wilkinson was issued 250,000 common shares valued at $162,500 pursuant to the Equity Compensation Plan.

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Earl Johnson, Chief Financial Officer of the Company, for gross wages of $36,000 (June 30, 2022 - $5,455).

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Chris White, a Director and Chief Information Security Officer of the Company, for management fees of $Nil (June 30, 2022 - $12,500) and gross wages of $20,000 (June 30, 2022 - $74,019).

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Troy Wilkinson, a Director of the Company, for management fees of $61,998 (June 30, 2022 - $62,500) and on May 25, 2023 Troy  Wilkinson was issued 250,000 common shares valued at $162,500 pursuant to the Equity Compensation Plan.

 

On May 25, 2023 Michael De Valera, a Director of the Company, was issued 100,000 common shares valued at $65,000 pursuant to the Equity Compensation Plan.

 

Other than the foregoing, none of the directors or executive officers of the Company, nor any person who owned of record or was known to own beneficially more than 5% of the Company’s outstanding shares of its Common Stock, nor any associate or affiliate of such persons or companies, has any material interest, direct or indirect, in any transaction that has occurred during the past fiscal year, or in any proposed transaction, which has materially affected or will affect the Company.

 

With regard to any future related party transaction, we plan to fully disclose any and all related party transactions in the following manner:

 

-

disclosing such transactions in reports where required;

-

disclosing in any and all filings with the SEC, where required;

-

obtaining disinterested directors consent; and

-

obtaining shareholder consent where required.

 

Review, Approval or Ratification of Transactions with Related Persons

 

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officers, Directors and significant stockholders. However, all of the transactions described above were approved and ratified by our Board of Directors. In connection with the approval of the transactions described above, our Board of Directors, took into account several factors, including their fiduciary duties to the Company; the relationships of the related parties described above to the Company; the material facts underlying each transaction; the anticipated benefits to the Company and related costs associated with such benefits; whether comparable products or services were available; and the terms the Company could receive from an unrelated third party.

 

We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. With regard to any future related party transaction, we plan to fully disclose any and all related party transactions in the following manner:

 

 -

disclosing such transactions in reports where required;

-

disclosing in any and all filings with the SEC, where required;

-

obtaining disinterested directors consent; and

-

obtaining shareholder consent where required.

 

 
56

Table of Contents

 

Director Independence

 

Quotations for our common stock are entered on the Over-the-Counter Bulletin Board inter-dealer quotation system, which does not have director independence requirements. For purposes of determining director independence, we apply the definitions set out in NASDAQ Rule 4200(a)(15). Under NASDAQ Rule 4200(a)(15), a director is not considered to be independent if he or she is also an executive officer or employee of the corporation. As a result, the we have one independent director, Michael De Valera, as our other directors are each also an executive officers or related to an executive officer.

  

Item 14. Principle Accountant Fees and Services

 

 

 

For Year Ended

June 30,

2023

 

 

For Year Ended

June 30,

2022

 

Audit Fees

 

$60,000

 

 

$45,000

 

Audit Related Fees

 

 

10,000

 

 

 

7,500

 

Tax Preparation

 

 

2,000

 

 

 

2,000

 

Total

 

$72,000

 

 

$54,500

 

 

Audit Fees consist of fees billed for professional services rendered for the audit of our financial statements and review of the interim financial statements included in quarterly reports and services that are normally provided by the above auditors in connection with statutory and regulatory fillings or engagements.

 

Audit-Related Fees are fees for assurance and related services by the principal accountant that are traditionally performed by the principal accountant and which are reasonably related to the performance of the audit or review of the registrant's financial statements and fees attributed to the audit of.

 

In the absence of a formal audit committee, the full Board of Directors pre-approves all audit and non-audit services to be performed by the independent registered public accounting firm in accordance with the rules and regulations promulgated under the Securities Exchange Act of 1934, as amended. The Board of Directors pre-approved 100% of the audit, audit-related and tax services performed by the independent registered public accounting firm for the fiscal periods ended June 30, 2023 and June 30, 2022.

 

 
57

Table of Contents

 

PART IV

 

Item 15. Exhibits and Financial Statements.

 

Exhibit

Number

 

Description

 

 

 

3.1

 

Articles of Incorporation filed with the Nevada Secretary of State on September 6, 2019 (2) 

3.2

 

Amendment to Company’s Articles of Incorporation increasing the authorized common stock from 50,000,000 to 100,000,000 (22)

3.3

 

Bylaws (2)

4.1

 

2021 Equity Compensation Plan (3)

10.1

 

Compilation of Website or Software Development Agreement and Addendum between Company and Cistck, dated June 4, 2020 (4)

10.2

 

Compilation of FirstFire Global Opportunities Fund, LLC Securities Purchase Agreement, Convertible Promissory Note and Other Agreements dated December 28, 2020 (5)

10.3

 

Compilation of GS Capital Partners, LLC Securities Purchase Agreement, Convertible Promissory Note and Other Agreements dated March 25, 2021 (6)

10.4

 

Compilation of Analytico Services Conseils Inc. Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated April 22, 2021 (7)

10.5

 

Compilation of Reynald Thauvette and Dominique Joyal  Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated April 28, 2021 (8)

10.6

 

Master Services Agreement between the Company and IONnovate, LLC dated September 3, 2021 (9)

10.7

 

Employment Agreement between the Company and Shannon Wilkinson dated January 3, 2022 (10)

10.8

 

Employment Agreement between the Company and Chris C. White dated January 3, 2022 (11)

10.9

 

Employment Agreement between the Company and Earl R. Johnson dated April 26, 2022 (12)

10.10

 

Compilation of AJB Capital Investments, LLC  Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated July 12, 2022 (13)

10.11

 

Compilation of Bigger Capital Fund, LP  Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated July 15, 2022 (14)

10.12

 

Compilation of District 2 Capital Fund LP Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated July 18, 2022 (15)

10.13

 

Employment Agreement between the Company and Alissa V. Knight dated July 26, 2022 (16)

10.14

 

Amendment to Employment Agreement between the Company and Chris C. White dated August 1,  2022 (17)

10.15

 

Compilation of AJB Capital Investments, LLC  Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated October 13, 2022 (18)

10.16

 

Compilation of Bigger Capital Fund, LP  Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated October 13, 2022 (19)

10.17

 

Compilation of District 2 Capital Fund LP Securities Purchase Agreement, Convertible Promissory Note and Warrant agreement dated October 13, 2022 (20)

10.18

 

Entry into Separation Agreement and Release with Chris C. White dated March 20, 2023 (21)

10.19

 

Entry into Separation Agreement and Release with Earl Johnson dated September 15, 2023 (23)

10.20

 

Entry into Consulting Agreement with Merremia Consulting LLC dated September 15, 2023 (24)

10.21

 

Entry into Employment Agreement with Robert Mikkelsen dated January 2, 2024 (25)

 

 

 

31.1

 

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)

31.2

 

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)

32.1

 

Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)

32.2

 

Certification of the Chief  Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)

 

101.INS*

 

Inline XBRL Instance Document

 

 

 

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

 

 

101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB*

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
58

Table of Contents

 

 

(1)*

Filed herewith.

 

(2)

Previously filed as an exhibit to our Form S-1 on September 21, 2020.

 

(3)

Previously filed as an exhibit to our Post Effective Form S-8 Amendment No 1. on February 18, 2022.

 

(4)

Previously filed as an exhibit to our Form S-1 Amendment No. 1 on October 27, 2020.

 

(5)

Previously filed with the SEC on December 31, 2020 as an exhibit to our Form 8-K.

 

(6)

Previously filed with the SEC on March 30, 2021 as an exhibit to our Form 8-K.

 

(7)

Previously filed with the SEC on April 26, 2021 as an exhibit to our Form 8-K.

 

(8)

Previously filed with the SEC on April 30, 2021 as an exhibit to our Form 8-K.

 

(9)

Previously filed with the SEC on September 16, 2021 as an exhibit to our Form 8-K.

 

(10)

Previously filed with the SEC on January 4, 2022 as an exhibit to our Form 8-K.

 

(11)

Previously filed with the SEC on January 4, 2022 as an exhibit to our Form 8-K.

 

(12)

Previously filed with the SEC on April 27, 2022 as an exhibit to our Form 8-K.

 

(13)

Previously filed with the SEC on July 15, 2022 as an exhibit to our Form 8-K.

 

(14)

Previously filed with the SEC on July 19, 2022 as an exhibit to our Form 8-K.

 

(15)

Previously filed with the SEC on July 20, 2022 as an exhibit to our Form 8-K.

 

(16)

Previously filed with the SEC on July 28, 2022 as an exhibit to our Form 8-K.

 

(17)

Previously filed with the SEC on August 2, 2022 as an exhibit to our Form 8-K.

 

(18)

Previously filed with the SEC on October 14, 2022 as an exhibit to our Form 8-K.

 

(19)

Previously filed with the SEC on October 17, 2022 as an exhibit to our Form 8-K.

 

(20)

Previously filed with the SEC on October 18, 2022 as an exhibit to our Form 8-K.

 

(21)

Previously filed with the SEC on March 23, 2023 as an exhibit to our Form 8-K.

 

(22)

Previously filed with the SEC on May 24, 2023 as an exhibit to our Form 8-K.

 

(23)

Previously filed with the SEC on September 19, 2023 as an exhibit to our Form 8-K.

 

(24)

Previously filed with the SEC on September 19, 2023 as an exhibit to our Form 8-K.

 

(25)

Previously filed with the SEC on January 4, 2024 as an exhibit to our Form 8-K.

 

Item 16. Form 10-K Summary

 

None.

 

 
59

Table of Contents

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Tego Cyber Inc.

 

 

 

 

 

Date: January 16, 2024

By:  

/s/ Robert Mikkelsen

 

 

 

Robert Mikkelsen 

 

 

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

Tego Cyber Inc.

 

 

 

 

 

Date: January 16, 2024

By:  

/s/ Robert Mikkelsen

 

 

 

Robert Mikkelsen 

 

 

 

Chief Financial  Officer

(Principal Financial and Accounting Officer)

 

 

 
60

 

nullnullnullnullv3.23.4
Cover - USD ($)
12 Months Ended
Jun. 30, 2023
Jan. 17, 2024
Cover [Abstract]    
Entity Registrant Name TEGO CYBER INC.  
Entity Central Index Key 0001815632  
Document Type 10-K  
Amendment Flag false  
Entity Voluntary Filers No  
Current Fiscal Year End Date --06-30  
Entity Well Known Seasoned Issuer No  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Jun. 30, 2023  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2023  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   53,776,616
Entity Public Float   $ 0
Document Annual Report true  
Document Transition Report false  
Document Fin Stmt Error Correction Flag false  
Entity File Number 000-56370  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 84-2678167  
Entity Address Address Line 1 8565 South Eastern Avenue  
Entity Address Address Line 2 Suite 150  
Entity Address City Or Town Las Vegas  
Entity Address State Or Province NV  
Entity Address Postal Zip Code 89123  
City Area Code 855  
Auditor Name M&K CPAS, PLLC  
Auditor Location The Woodlands, TX  
Local Phone Number 939-0100  
Security 12g Title Common Stock, par value $0.001  
Entity Interactive Data Current Yes  
Auditor Firm Id 2738  
v3.23.4
BALANCE SHEETS - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Current assets    
Cash $ 181,246 $ 47,742
Accounts receivable 0 1,150
Prepaid expenses (Note 5) 30,226 41,119
Total current assets 211,472 90,011
Other assets 25,000 25,000
Computer equipment, net 0 3,207
Software (Note 6) 0 411,122
TOTAL ASSETS 236,472 529,340
Current liabilities    
Accounts payable (Note 7) 129,273 66,066
Notes payable (Note Convertible debts 891,694 0
TOTAL LIABILITIES 1,020,967 66,066
SHAREHOLDERS' EQUITY    
Common shares 100,000,000 shares authorized $0.001 par value 47,343,282 shares issued and outstanding at June 30, 2023 and 25,508,044 shares at June 30, 2022 47,343 25,508
Additional paid in capital 14,054,838 4,586,049
Accumulated deficit (14,886,676) (4,148,283)
TOTAL SHAREHOLDERS' EQUITY (784,495) 463,274
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY $ 236,472 $ 529,340
v3.23.4
BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2023
Jun. 30, 2022
BALANCE SHEETS    
Common stock, par value $ 0.001 $ 0.001
Common stock, authorized 100,000,000 100,000,000
Common stock, issued 47,343,282 25,508,044
Common stock, outstanding 47,343,282 25,508,044
v3.23.4
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
REVENUE    
Consulting fees $ 0 $ 1,050
Subscription Revenue 0 2,500
TOTAL REVENUE 0 3,550
OPERATING EXPENSES    
General & administration 4,878,234 1,258,539
Professional fees 582,565 749,607
Sales & marketing 369,894 171,211
Share based compensation 0 905,962
TOTAL OPERATING EXPENSES 5,830,693 3,085,319
NET OPERATING LOSS (5,830,693) (3,081,769)
OTHER INCOME (EXPENSE)    
Accretion expense (653,980) (66,132)
Financing fees (3,607,449) 0
Impairment of software (646,271) 0
TOTAL OTHER INCOME (EXPENSE) (4,907,700) (66,132)
NET LOSS $ (10,738,393) $ (3,147,901)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.33) $ (0.13)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 32,871,748 24,184,384
v3.23.4
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscription Receivable [Member]
Accumulated Deficit
Balance, shares at Jun. 30, 2021   18,296,511      
Balance, amount at Jun. 30, 2021 $ 728,046 $ 18,297 $ 1,720,631 $ (10,500) $ (1,000,382)
Shares issued for cash, shares   5,558,810      
Shares issued for cash, amount 1,425,202 $ 5,558 1,409,144 10,500 0
Shares issued for services, shares   715,572      
Shares issued for services, amount 458,250 $ 716 457,534 0 0
Shares issued for settlement of convertible debts, shares   937,151      
Shares issued for settlement of convertible debts, amount 93,715 $ 937 92,778 0 0
Share-based compensation 905,962 0 905,962 0 0
Net loss for the year ended June 30, 2022 (3,147,901) $ 0 0 0 (3,147,901)
Balance, shares at Jun. 30, 2022   25,508,044      
Balance, amount at Jun. 30, 2022 463,274 $ 25,508 4,586,049 0 (4,148,283)
Shares issued for services, shares   3,953,572      
Shares issued for services, amount 2,096,304 $ 3,953 2,092,351 0 0
Share-based compensation 1,993,585 1,100 1,992,485 0 0
Net loss for the year ended June 30, 2022 (10,738,393) $ 0 0 0 (10,738,393)
Shares issued as transaction costs for notes payable, shares   1,533,333      
Warrants issued as transaction costs for notes payable 324,419 $ 0 324,419    
Shares issued as transaction costs for notes payable, amount 247,867 $ 1,534 246,333 0 0
Shares issued from private placements, shares   12,970,000      
Shares issued from private placements, amount 1,297,000 $ 12,970 1,284,030 0 0
Shares issued for debts, shares   45,000      
Shares issued for debts, amount 9,000 $ 45 8,955 0 0
Share-based compensation, shares   1,100,000      
Shares issued for financing fees, shares   2,233,333      
Shares issued for financing fees, amount 1,674,999 $ 2,233 1,672,766 0 0
Warrants issued for financing fees, amount 1,847,450 $ 0 1,847,450 0 0
Balance, shares at Jun. 30, 2023   47,343,282      
Balance, amount at Jun. 30, 2023 $ (784,495) $ 47,343 $ 14,054,838 $ 0 $ (14,886,676)
v3.23.4
STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss for the year $ (10,738,393) $ (3,147,901)
Items not affecting cash    
Shares issued for services 2,096,304 458,250
Interest on short term debt 0 4,962
Amortization 95,703 3,370
Accretion expense 653,980 66,132
Impairment of software 646,271 0
Share-based compensation 1,993,585 905,962
Financing fees in settlement of default 3,522,449 0
Changes in non-cash working capital items:    
Accounts receivable 1,150 300
Prepaid expenses 10,893 47,343
Accounts payable and accrued liabilities 72,207 43,056
NET CASH USED IN OPERATING ACTIVITIES (1,645,851) (1,618,526)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of computer equipment 0 (6,577)
Capitalized software development costs (327,645) (335,372)
NET CASH USED IN INVESTING ACTIVITIES (327,645) (341,949)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from shares issued 0 1,425,202
Proceeds from private placements 1,297,000 0
Cash received from issuance of notes payable 810,000 0
NET CASH PROVIDED BY FINANCING ACTIVITIES 2,107,000 1,425,202
NET INCREASE (DECREASE) IN CASH 133,504 (535,273)
CASH AT BEGINNING OF THE PERIOD 47,742 583,015
CASH AT END OF THE PERIOD 181,246 47,742
Non-cash investing and financing activities:    
Shares issued as transaction costs with notes payable (572,286) 0
Shares issued for settlement of debt $ 9,000 $ 93,715
v3.23.4
ORGANIZATION AND DESCRIPTION OF BUSINESS
12 Months Ended
Jun. 30, 2023
ORGANIZATION AND DESCRIPTION OF BUSINESS  
ORGANIZATION AND DESCRIPTION OF BUSINESS

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Tego Cyber Inc. is an early-stage company which was incorporated in the State of Nevada on September 6, 2019. Our year end is June 30. We are a development stage enterprise. We are engaged in the business of the development and commercialization of innovative cybersecurity applications that help enterprises reduce risk, remediate cyber-attacks, and protect intellectual property and data.

 

Our principal office is located at 8565 South Eastern Avenue, Suite 150, Las Vegas, Nevada, 89123. Our telephone number is (855) 939-0100 and our general e-mail contact is info@tegocyber.com. Our website can be viewed at www.tegocyber.com.

v3.23.4
BASIS OF PRESENTATION
12 Months Ended
Jun. 30, 2023
BASIS OF PRESENTATION  
BASIS OF PRESENTATION

NOTE 2 – BASIS OF PRESENTATION

 

The accompanying audited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). In the opinion of management, the financial statements include all adjustments of a normal recurring nature necessary for a fair statement of the results for the period presented.

 

The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and the statements of cash flows of the Company for the years ended June 30, 2023 and 2022. The accompanying audited financial statements have been prepared in accordance with US GAAP using Company-specific information where available and allocations and estimates where data is not maintained on a Company-specific basis within its books and records. Due to the allocations and estimates used to prepare the financial statements, they may not reflect the financial position, cash flows and results of operations of the Company in the future or its operations, cash flows and financial position.

 

The preparation of financial statements in accordance with US GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of the Company’s financial position and results of operations.

v3.23.4
GOING CONCERN UNCERTAINTY
12 Months Ended
Jun. 30, 2023
GOING CONCERN UNCERTAINTY  
GOING CONCERN UNCERTAINTY

NOTE 3 – GOING CONCERN UNCERTAINTY

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At June 30, 2023, the Company had a working capital deficit of $809,495. For the year ended June 30, 2023, the Company sustained net losses of $10,738,393 and generated negative cash flows from operations of $1,645,851. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

v3.23.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the financial statements. The financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of the financial statements.

 

Basis of Preparation

 

The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and statements of cash flows of the Company for the period ended June 30, 2023 and 2022 and have been prepared in accordance with US GAAP.

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at June 30, 2023, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

 

Cash

 

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

 

Receivables and Allowance for Doubtful Accounts

 

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the period ended June 30, 2023 and 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of June 30, 2023 and 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

 

Software

 

Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years. During the year ended June 30, 2023, management identified indicators of impairment on its software and software under development. The indicators consisted of a current and historic cash flow loss from operations. As a result, management performed an impairment test that resulted in the recognition of an impairment loss of $646,271 on the software assets.  

 

Research and Development Costs

 

Research and Development Costs are expensed as incurred. During the years ended June 30, 2023 and 2022, the Company incurred $nil research and development costs.

 

Advertising Costs

 

Advertising Costs are expensed as incurred. During the years ended June 30, 2023 and 2022, the Company incurred $nil advertising costs.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

 

Fair Value of Financial Instruments

 

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at June 30, 2023. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.

 

Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.

 

Revenue Recognition

 

Revenue is recognized under ASC 606, “Revenue from Contracts with Customers” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services.

 

Revenue for the fiscal years ended June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Consulting fees

 

$-

 

 

$1,050

 

Subscription revenue

 

 

-

 

 

 

2,500

 

Total

 

$-

 

 

$3,550

 

 

The Company currently has not generated any revenue from its threat intelligence software.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. Dilutive securities are not included in the weighted average number of shares when inclusion would be anti-dilutive. The following table summarizes the securities outstanding and exercisable, (regardless of exercise price) at June 30, 2023 and 2022 that were excluded from the diluted net loss per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss.

 

 

 

2023

 

 

2022

 

Potentially dilutive common share equivalents

 

 

 

 

 

 

Options

 

 

1,200,000

 

 

 

-

 

Warrants

 

 

4,500,000

 

 

 

3,014,246

 

Performance Stock Units

 

 

2,700,000

 

 

 

4,000,000

 

Potentially dilutive shares outstanding

 

 

8,400,000

 

 

 

7,014,246

 

 

Recently Issued Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

v3.23.4
PREPAID EXPENSES
12 Months Ended
Jun. 30, 2023
PREPAID EXPENSES  
PREPAID EXPENSES

NOTE 5 – PREPAID EXPENSES

 

Prepaid expense balance as of June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Advertising & promotion

 

$-

 

 

$5,500

 

Consultants & contractors

 

 

-

 

 

 

5,301

 

Platform costs

 

 

-

 

 

 

30,318

 

Software development

 

 

30,226

 

 

 

-

 

Total

 

$30,226

 

 

$41,119

 

v3.23.4
SOFTWARE
12 Months Ended
Jun. 30, 2023
SOFTWARE  
SOFTWARE

NOTE 6 – SOFTWARE

 

The Company has completed the first version of its technology for integration with the Splunk SIEM platform. That product is now commercially available. The Company is currently developing versions of its application for integration with AWS Security Lake and Elastic SIEM platform.

 

Balance, June 30, 2021

 

$75,750

 

Additions

 

 

335,372

 

Depreciation

 

 

-

 

Balance, June 30, 2022

 

 

411,122

 

Additions

 

 

327,645

 

Depreciation

 

 

(92,496 )

Impairment

 

 

(646,271 )

Balance, June 30, 2023

 

$-

 

 

During the year ended June 30, 2023, management identified indicators of impairment on its software and software under development. The indicators consisted of a current and historic cash flow loss from operations. As a result, management performed an impairment test that resulted in the recognition of an impairment loss of $646,271 on the software assets.

v3.23.4
ACCOUNTS PAYABLE
12 Months Ended
Jun. 30, 2023
ACCOUNTS PAYABLE  
ACCOUNTS PAYABLE

NOTE 7 – ACCOUNTS PAYABLE

 

Accounts payable balance as of June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Advertising & promotion

 

$45,000

 

 

$-

 

Legal & accounting

 

 

38,988

 

 

 

23,247

 

Software development

 

 

41,415

 

 

 

42,819

 

Travel

 

 

1,358

 

 

 

-

 

Accrued interest on short term debt

 

 

2,512

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total

 

$129,273

 

 

$66,066

 

v3.23.4
RELATED PARTY TRANSACTIONS
12 Months Ended
Jun. 30, 2023
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Shannon Wilkinson, a Director, CEO, President, Secretary and Treasurer of the Company, for management fees of $Nil (June 30, 2022 - $101,750), gross wages of $122,500 (June 30, 2022 - $98,692) and on May 25, 2023 Shannon Wilkinson was issued 250,000 common shares valued at $0 pursuant to the Company’s 2021 Equity Compensation Plan. As discussed further in note 10, the expense for shares issued is being recorded over the term of the performance units.

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Earl Johnson, Chief Financial Officer of the Company, for gross wages of $36,000 (June 30, 2022 - $5,455). At his separation date, the Company owed Mr. Johnson approximately $10,000 in gross wages The Company issued Mr. Johnson 100,000 shares of restricted common stock as part of a standard settlement and release agreement. 

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Chris White, a Director and Chief Information Security Officer of the Company, for management fees of $Nil (June 30, 2022 - $12,500) and gross wages of $20,000 (June 30, 2022 - $74,019). At his separation date, the Company owed Mr. White approximately $20,000 in gross wages. The Company issued Mr. White 100,000 shares of restricted common stock as part of a standard settlement and release agreement. 

 

During the year ended June 30, 2023, there were transactions incurred between the Company and Troy Wilkinson, a Director of the Company, for management fees of $61,998 (June 30, 2022 - $62,500) and on May 25, 2023 Troy Wilkinson was issued 250,000 common shares valued at $0 pursuant to the Company’s 2021 Equity Compensation Plan. As discussed further in note 10, the expense for shares issued is being recorded over the term of the performance units

 

On May 25, 2023 Michael De Valera, a Director of the Company, was issued 100,000 common shares valued at $0 pursuant to the Company’s 2021 Equity Compensation Plan. As discussed further in note 10, the expense for shares issued is being recorded over the term of the performance units.

v3.23.4
NOTES PAYABLE (convertible only at default)
12 Months Ended
Jun. 30, 2023
NOTES PAYABLE (convertible only at default)  
NOTES PAYABLE (convertible only at default)

NOTE 9 – NOTES PAYABLE (convertible only at default)

 

 

(a)

On July 12, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $300,000 at $270,000 with a $30,000 original issue discount. In connection with this note, the Company paid an additional $27,500 in cash transaction costs, issued 350,000 common shares valued at $178,500 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. The warrants were calculated to have a fair value of $249,971 as at July 12, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On January 11, 2023, the Company and the lender agreed to extend the maturity date to July 12, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $102,943.

 

The Company also agreed to pay a commitment fee of $178,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 350,000 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $73,510.

 

As at June 30, 2023, the carrying value of this note payable was $299,926 (June 30, 2022 - $Nil) net of $74 unamortized discounts.

 

 

 

 

(b)

On July 15, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $89,250 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 15, 2027. The warrants were calculated to have a fair value of $124,984 as at July 15, 2022. This promissory note is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On January 11, 2023, the Company and the lender agreed to extend the maturity date to July 12, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $51,471.

 

 

The Company also agreed to pay a commitment fee of $89,250 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $36,755.

 

As at June 30, 2023, the carrying value of this note payable was $149,963 (June 30, 2022 - $Nil) net of $37 unamortized discounts.

 

 

 

 

(c)

On July 18, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable e in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $89,250 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 18, 2027. The warrants were calculated to have a fair value of $124,994 as at July 18, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On January 11, 2023, the Company and the lender agreed to extend the maturity date to July 12, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $51,474.

 

The Company also agreed to pay a commitment fee of $89,250 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $36,755.

 

As at June 30, 2023, the carrying value of this note payable was $149,962 (June 30, 2022 - $Nil) net of $38 unamortized discounts.

 

(d)

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with a $15,000 original issue discount. In connection with this note, the Company paid an additional $23,750 in cash transaction costs, issued 416,667 common shares valued at $187,625 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $220,526 as at October 13, 2022. This note payable matures on April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On April 12, 2023, the Company and the lender agreed to extend the maturity date to October 13, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 15% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $59,265.

 

The Company also agreed to pay a commitment fee of $187,625 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 416,667 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $50,423.

 

As at June 30, 2023, the carrying value of this note payable was $145,923 (June 30, 2022 - $Nil) net of $4,077 unamortized discounts.

 

 

 

 

(e)

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $67,500 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,333 common shares valued at $93,812 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $110,263 as at October 13, 2022. This promissory note matures on April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

On April 12, 2023, the Company and the lender agreed to extend the maturity date to October 13, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $29,633.

 

The Company also agreed to pay a commitment fee of $93,812 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 208,333 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $25,212.

 

As at June 30, 2023, the carrying value of this note payable was $72,960 (June 30, 2022 - $Nil) net of $2,040 unamortized discounts.

 

 

 

 

(f)

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $67,500 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,333 common shares valued at $93,812 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $110,263 as at October 13, 2022. This promissory note matures on April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

 

 

On April 12, 2023, the Company and the lender agreed to extend the maturity date to October 13, 2023 and increase the interest rate to 15% while the remaining terms stayed unchanged. Under ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), the Company assessed whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different if the present value of the cash flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the original instrument. Since the difference was greater than 10 percent, the extension of the maturity date and the increase in the interest rate were considered to be an extinguishment of the original debt instrument.

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 10% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $29,633.

 

The Company also agreed to pay a commitment fee of $93,812 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 208,333 common shares of the Company. Under ASC 835 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $25,212.

 

As at June 30, 2023, the carrying value of this note payable was $72,960 (June 30, 2022 - $Nil) net of $2,040 unamortized discounts.

v3.23.4
COMMON SHARES
12 Months Ended
Jun. 30, 2023
COMMON SHARES  
COMMON SHARES

NOTE 10 – COMMON SHARES

 

Common Stock

 

At June 30, 2023, the Company’s authorized capital consisted of 100,000,000 of common shares with a $0.001 par value and 47,343,282 shares were issued and outstanding.

 

During the year ended June 30, 2023, the Company incurred the following transactions:

 

On July 12, 2022, the Company issued 350,000 common shares at a relative fair value of $0.21 per share for transaction costs associated with the issuance of a note payable.

 

On July 15, 2022, the Company issued 175,000 common shares at a relative fair value of $0.21 per share for transaction costs associated with the issuance of a note payable.

 

On July 18, 2022, the Company issued 175,000 common shares at a relative fair value of $0.21 per share for transaction costs associated with the issuance of a note payable.

 

On July 26, 2022, the Company issued 275,000 common shares at a price of $0.51 (market price at the time of agreement) per share for marketing and branding services valued at $140,250.

 

On October 12, 2022, the Company issued 416,667 common shares at a relative fair value of $0.12 per share for transaction costs associated with the issuance of a note payable.

On October 13, 2022, the Company issued 208,333 common shares at a relative fair value of $0.12 per share for transaction costs associated with the issuance of a note payable.

 

On October 13, 2022, the Company issued 208,333 common shares at a relative fair value of $0.12 per share for transaction costs associated with the issuance of a note payable.

 

On November 29, 2022, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On December 5, 2022, the Company completed a private placement whereby a total of 400,000 common shares were sold for cash at a price of $0.10 per share for a total value of $40,000.

 

On January 6, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 9, 2023, the Company issued 500,000 common shares at a price of $0.20 (market price at the time of agreement) to a non-related party in exchange for services.

 

On January 9, 2023, the Company issued 45,000 common shares at a price of $0.20 (market price at the time of agreement) per share to a non-related party in exchange for settlement of a debt.

 

On January 11, 2023, the Company completed a private placement whereby a total of 300,000 common shares were sold for cash at a price of $0.10 per share for a total value of $30,000.

 

On January 15, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.10 per share for a total value of $60,000.

 

On January 16, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 17, 2023, the Company completed various private placements whereby a total of 70,000 common shares were sold for cash at a price of $0.10 per share for a total value of $7,000.

 

On January 21, 2023, the Company completed various private placements whereby a total of 1,130,000 common shares were issued for cash at a price of $0.10 per share for a total value of $113,000.

 

On January 23, 2023, the Company completed various private placements whereby a total of 430,000 common shares were sold for cash at a price of $0.10 per share for a total value of $43,000.

 

On January 24, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000.

 

On January 25, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 28, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 30, 2023, the Company completed various private placements whereby a total of 850,000 common shares were sold for cash at a price of $0.10 per share for a total value of $85,000.

 

On February 6, 2023, the Company issued 1,000,000 common shares at a price of $0.18 (market price at the time of agreement) per share to a non-related party in exchange for services.

 

On February 6, 2023, the Company completed various private placements whereby a total of 225,000 common shares were sold for cash at a price of $0.10 per share for a total value of $22,500.

On February 7, 2023, the Company completed various private placements whereby a total of 215,000 common shares were sold for cash at a price of $0.10 per share for a total value of $21,500.

 

On February 14, 2023, the Company completed various private placements whereby a total of 1,350,000 common shares were sold for cash at a price of $0.10 per share for a total value of $135,000.

 

On February 15, 2023, the Company completed a private placement whereby a total of 250,000 common shares were sold for cash at a price of $0.10 per share for a total value of $25,000.

 

On July 13, 2022, the Company entered into a securities purchase agreement with a non-related party in which the Company had issued a convertible debt in the principal amount of $300,000 at $270,000 cash with $30,000 original issue discount. In this agreement, the Company had issued 150,000 common shares and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. However, the Company and the non-related party have agreed and confirmed that certain Events of Default have occurred, including the Company’s failures to comply with its obligations and covenants with respect to: (i) failures to file registration statements and (ii) failures to comply with its obligations regarding the Subsequent Financings and the Purchaser’s rights thereto. As a result, on March 12, 2023, the Company and the non-related party have entered into a letter agreement in which the Company agreed to issue to the non-related party 2,233,333 restricted shares of the Company’s common stock at a price per share of $0.75 immediately upon the execution of the letter agreement as well as an additional 2,500,000 warrant shares exercisable at $0.25 per share. All other terms and conditions are to remain from the original agreement.

 

On March 23, 2023, the Company issued 2,000,000 common shares at a price of $0.78 (market price at the time of agreement) per share to a non-related party in exchange for services.

 

On March 24, 2023, the Company completed a private placement whereby a total of 750,000 common shares were sold for cash at a price of $0.10 per share for a total value of $75,000.

 

On April 4, 2023, the Company issued 100,000 common shares at a price of $1.04 (market price at the time of agreement) per share to a former employee as part of release and settlement agreement.

 

On April 10, 2023, the Company issued 100,000 common shares at a price of $0.85 (market price at the time of agreement) per share to a former consultant as part of release and settlement agreement.

 

On May 24, 2023, the Company completed a private placement whereby a total of 3,930,000 common shares were sold for cash at a price of $0.10 per share for a total value of $393,000.

 

On May 24, 2023, the Company completed a private placement whereby a total of 170,000 common shares were sold for cash at a price of $0.10 per share for a total value of $17,000.

 

On May 25, 2023, the Company issued 900,000 common shares to the directors and consultants from exercising their rights embedded with the performance stock units as they became exercisable. The expense was partially recorded in the current and prior years, at the time the performance stock units were granted.

 

On June 1, 2023, the Company issued 178,572 common shares at a price of $0.65 (market price at the time of agreement) per share to a non-related party in exchange for services.

 

On June 16, 2023, the Company completed a private placement whereby a total of 700,000 common shares were sold for cash at a price of $0.10 per share for a total value of $70,000.

 

During the year ended June 30, 2022, the Company incurred the following transactions:

 

During the period July 1, 2021 to October 28, 2021, the Company completed various private placements whereby a total of 5,558,810 common shares were issued for a total proceeds of $1,425,202.

 

On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for marketing services valued at $100,000.

On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000.

 

On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for consulting services valued at $35,250.

 

On December 31, 2021, the Company issued 583,936 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $58,394. See Note 10 (a).

 

On December 31, 2021, the Company issued 353,215 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $35,321. See Note 10 (b).

 

On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for consulting services valued at $65,000.

 

On March 25, 2022, the Company issued 12,000 common shares to a non-related party at a price of $0.60 per share for a total value of $7,200 in exchange for services.

 

On May 19, 2022, the Company issued 400,000 common shares to a non-related party at a price of $0.577 per share for investor relations services valued at $230,800.

 

Warrants

 

On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $148,438 using the Black Scholes Option Pricing Model. These warrants expired during the three months ended March 31, 2023.

 

On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $399,087 using the Black Scholes Option Pricing Model.

 

On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $196,399 using the Black Scholes Option Pricing Model.

 

On July 12, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $249,971 using the Black Scholes Option Pricing Model and they were recorded at $102,943 in additional paid-in capital using the relative fair value method.

 

On July 15, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $124,984 using the Black Scholes Option Pricing Model and they were recorded at $51,471 in additional paid-in capital using the relative fair value method.

 

On July 18, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $124,994 using the Black Scholes Option Pricing Model and they were recorded at $51,474 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $220,526 using the Black Scholes Option Pricing Model and they were recorded at $59,265 in additional paid-in capital using the relative fair value method.

On October 13, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $110,263 using the Black Scholes Option Pricing Model and they were recorded at $29,633 in additional paid-in capital using the relative fair value method.

 

On October 13, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $110,263 using the Black Scholes Option Pricing Model and they were recorded at $29,633 in additional paid-in capital using the relative fair value method.

 

On March 12, 2023, the Company granted 2,500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $1,847,450 using the Black Scholes Option Pricing Model.

 

The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants.

 

 

 

June 30,

2023

 

Stock price

 

$0.17 - $1.10

 

Risk-free interest rate

 

3.01% - 4.21

%

Expected life

 

5 Years

 

Expected dividend rate

 

 

0

 

Expected volatility

 

192.940% - 195.25

%

 

Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows:

 

 

 

Number

of

Warrants

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2021

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

4,500,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

(3,014,246 )

 

 

-

 

Outstanding, June 30, 2023

 

 

4,500,000

 

 

$0.25

 

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted Average

Life (Years)

 

 

Expiry

Date

 

July 12, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

 

0.45

 

 

July 12, 2027

 

July 15, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.22

 

 

July 15, 2027

 

July 18, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.23

 

 

July 18, 2027

 

October 13, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

 

0.48

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.24

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.24

 

 

October 13, 2027

 

March 12, 2023

 

 

2,500,000

 

 

 

2,500,000

 

 

 

0.25

 

 

 

2.61

 

 

March 12, 2028

 

Total

 

 

4,500,000

 

 

 

4,500,000

 

 

 

0.25

 

 

 

4.46

 

 

 

 

 

As of June 30, 2023, the weighted average remaining contractual life of warrants outstanding was 4.46 years with an intrinsic value of $0.

Stock Options

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

During the year ended June 30, 2023 the Company issued a total of 6,000,000 non-qualified stock options (the “options”) to directors, officers and certain key consultants. The options are subject to the terms and conditions of the Equity Compensation Plan. All granted options are subject to a five-year vesting schedule equal to 20% per year starting on the 1st day of each year following the effective date. All options have an exercise price of $0.65 which was the closing price of the Company’s common stock on the day the day grant.

 

The following is a continuity schedule for the Company’s outstanding non-qualified stock options:

 

 

 

Number of

options

 

 

Weighted Average

Exercise

Price

 

Outstanding, June 30, 2021

 

 

-

 

 $

 

 Granted

 

 

 6,000,000

 

 

 0.65

 

 Exercised

 

 

 -

 

 

-

 

 Cancelled

 

 

 -

 

 

 -

 

Outstanding, June 30, 2022

 

 

 6,000,000

 

 $

0.65

 

Granted

 

 

125,000

 

 

 0.65

 

Exercised

 

 

-

 

 

-

 

Cancelled

 

 

(125,000)

 

0.65

 

Outstanding, June 30, 2023

 

 

6,000,000

 

 $

 0.65

 

 

As at June 30, 2023, the Company had the following stock options outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted Average Life (Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

25,000

 

 

0.65

 

 

8.52

 

 

January 3, 2032

 

January 4, 2022

 

 

5,750,000

 

 

 

1,150,000

 

 

0.65

 

 

8.52

 

 

January 4, 2032

 

March 1, 2023

 

 

125,000

 

 

 

25,000

 

 

0.65

 

 

8.52

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

1,200,000

 

 

0.65

 

 

8.52

 

 

 

 

 

During the year ended June 30, 2023, the Company recorded $1,070,990 as share-based compensation relating to the issuance of the non-qualified stock options with an intrinsic value of $0.

 

The fair value of the options granted during the year ended June 30, 2023 was estimated on the date of the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Expected volatility

 

187.07

%

Expected option life (years)

 

6 years

 

Risk-free interest rate (10-year U.S. treasury yield)

 

4.22

%

Expected dividend yield

 

 

0%

 

Performance Stock Units

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

During the year ended June 30, 2022 the Company issued a total of 4,000,000 performance stock units (“performance units”) to directors, officers and certain key consultants. The performance units are subject to the terms and conditions of the Equity Compensation Plan. The performance units will be earned and vest upon reaching certain market capitalization goals during the performance period ending on December 31, 2026.

 

Each unit represents one common share:

 

Number of Performance Units

 

 

Vesting Conditions

 

Expiry Dates

 

-

 

 

Market capitalization of the Company reaches $25 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $50 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $75 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $100 million

 

December 31, 2026

 

On March 20, 2023, the Company terminated its employment relationship with one of the unit holders who had 400,000 performance stock units where the rights had been cancelled.

 

During the year ended June 30, 2023, the Company’s market capitalization reached over $25 million and the unit holders exercised 900,000 options in exchange for 900,000 common shares. Intrinsic value varies for each vesting condition based on stock price at the time. None of the outstanding units are exercisable as of June 30, 2023.

 

The following is a continuity schedule for the Company’s outstanding performance stock units:

 

 

 

Number of

Performance Units

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

(900,000)

 

 

-

 

Forfeited or cancelled

 

 

(400,000)

 

 

-

 

Outstanding, June 30, 2022

 

 

2,700,000

 

 

$-

 

 

As of June 30, 2022, the Company had the following performance units outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted

Average Life

(Years)

 

 

Expiry

Date

 

March 8, 2022

 

 

2,700,000

 

 

 

-

 

 

USD $0.00

 

 

3.51

 

 

December 31, 2026

 

Total

 

 

2,700,000

 

 

 

-

 

 

USD $0.00

 

 

3.51

 

 

 

 

 

During the year ended June 30, 2023, the Company recorded $475,453 as share-based compensation relating to the issuance of the performance units. $775,301 has been recorded as share-based compensation relating to the outstanding performance units to date. The remaining $124,699 will be recorded as share-based compensation over the remaining life of the units.

 

No performance units were granted during the year ended June 30, 2023.The fair value of the performance units granted during the year ended June 30, 2022 was estimated on the date of the grant date using output from a Black-Sholes model to calculate the value of the award multiplying by the current stock price as of the valuation date with the following weighted average assumptions:

 

Expected volatility

 

 

85.0%

Requisite period

 

4.00 years

 

Risk-free interest rate (US Treasury Bond rate as of the grant date)

 

 

1.80%

Expected dividend yield

 

 

0%
v3.23.4
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

v3.23.4
INCOME TAXES
12 Months Ended
Jun. 30, 2023
INCOME TAXES  
INCOME TAXES

NOTE 12 – INCOME TAXES

 

As of June 30, 2023, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax.

 

Net operating loss carry forward of the Company, amounted to $6,818,462 (June 30, 2022 - $2,909,935) for the year ended June 30, 2023. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2043. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.

v3.23.4
RECLASSIFICATION OF PRIOR YEAR PRESENTATION
12 Months Ended
Jun. 30, 2023
RECLASSIFICATION OF PRIOR YEAR PRESENTATION  
RECLASSIFICATION OF PRIOR YEAR PRESENTATION

NOTE 13 – RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are limited to the Balance Sheet and Statement of Operations and have no effect on the reported results of operations.

v3.23.4
SUBSEQUENT EVENTS
12 Months Ended
Jun. 30, 2023
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 14 – SUBSEQUENT EVENTS

 

On July 3, 2023, the Company granted 1,250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $710,118 using the Black Scholes Option Pricing Model.

 

With reference to the Side Letter received on July 3, 2023 from the above lender, the Company agreed to issue 1,116,667 common shares at a price per share of $0.10 (the “Additional Commitment Fee Shares”) as consideration specified in the purchase agreements.

 

With regards to the securities purchase agreement entered on July 15, 2022 with above lender, the Company and the lender agreed to increase the principal amount of the note by $15,000, which amount would bear interest as set forth in the July 2022 Note and extend the maturity date to August 14, 2023.

 

On July 3, 2023, the Company granted 1,250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to another lender as part of a default settlement related to a note payable financing transaction (Note 9). The warrants were valued at $710,118 using the Black Scholes Option Pricing Model.

 

With reference to the Side Letter received on July 3, 2023 from the above lender, the Company agreed to issue 1,116,667 common shares at a price per share of $0.10 as consideration specified in the purchase agreements.

 

With regards to the securities purchase agreement entered on July 15, 2022 with above lender, the Company and the lender agreed to increase the principal amount of the note by $15,000, which amount would bear interest as set forth in the July 2022 Note and extend the maturity date to August 14, 2023.

 

On July 3, 2023, the Company issued 100,000 common shares at a price of $0.65 per share to members of the newly appointed advisory board.

 

On July 3, 2023, the Company issued 250,000 common shares at a price of $0.48 per share to non-related parties in exchange for services.

 

On July 27, 2023, the Company completed a private placement whereby a total of 500,000 common shares were sold for cash at a price of $0.10 per share for a total value of $50,000.

 

On August 17, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On August 21, 2023, the Company issued 800,000 common shares at a price of $0.10 per share as consideration for extension of the maturity date related to a note payable financing transaction (Note 9).

 

On August 22, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.15 per share for a total value of $90,000.

 

On September 1, 2023, the Company made a $50,000 payment on an outstanding note payable financing transaction (Note 9).

 

On September 15, 2023, the Company issued 100,000 common shares at a price of $0.2328 per share to the former Chief Financial Officer pursuant to a Separation Agreement and Release.

 

On September 15, 2023, the Company issued 250,000 common shares at a price of $0.2328 per share to its newly appointed Chief Financial Officer pursuant to a Consulting Agreement.

 

On September 19, 2023, the Company issued 500,000 common shares at a price of $0.22 per share to a non-related party in exchange for services.

 

On September 20, 2023, the Company received a purchase order for a license fee for its threat correlation application for integration with Splunk.

 

On October 6, 2023, the Company issued 1,000,000 common shares at a price of $0.10 per share as consideration for extension of the maturity date related to a note payable financing transaction (Note 9).

v3.23.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Preparation

The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and statements of cash flows of the Company for the period ended June 30, 2023 and 2022 and have been prepared in accordance with US GAAP.

Use of Estimates

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at June 30, 2023, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

Cash

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

Receivables and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the period ended June 30, 2023 and 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of June 30, 2023 and 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

Software

Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years. During the year ended June 30, 2023, management identified indicators of impairment on its software and software under development. The indicators consisted of a current and historic cash flow loss from operations. As a result, management performed an impairment test that resulted in the recognition of an impairment loss of $646,271 on the software assets.  

Research and Development Costs

Research and Development Costs are expensed as incurred. During the years ended June 30, 2023 and 2022, the Company incurred $nil research and development costs.

Advertising Costs

Advertising Costs are expensed as incurred. During the years ended June 30, 2023 and 2022, the Company incurred $nil advertising costs.

Leases

The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at June 30, 2023. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.

 

Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.

Revenue Recognition

Revenue is recognized under ASC 606, “Revenue from Contracts with Customers” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services.

 

Revenue for the fiscal years ended June 30, 2023 and June 30, 2022 consisted of the following:

 

 

 

June 30,

2023

 

 

June 30,

2022

 

Consulting fees

 

$-

 

 

$1,050

 

Subscription revenue

 

 

-

 

 

 

2,500

 

Total

 

$-

 

 

$3,550

 

The Company currently has not generated any revenue from its threat intelligence software.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

Earnings (Loss) per Share

Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. Dilutive securities are not included in the weighted average number of shares when inclusion would be anti-dilutive. The following table summarizes the securities outstanding and exercisable, (regardless of exercise price) at June 30, 2023 and 2022 that were excluded from the diluted net loss per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss.

 

 

 

2023

 

 

2022

 

Potentially dilutive common share equivalents

 

 

 

 

 

 

Options

 

 

1,200,000

 

 

 

-

 

Warrants

 

 

4,500,000

 

 

 

3,014,246

 

Performance Stock Units

 

 

2,700,000

 

 

 

4,000,000

 

Potentially dilutive shares outstanding

 

 

8,400,000

 

 

 

7,014,246

 

Recently Issued Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

v3.23.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Revenue Recognition

 

 

June 30,

2023

 

 

June 30,

2022

 

Consulting fees

 

$-

 

 

$1,050

 

Subscription revenue

 

 

-

 

 

 

2,500

 

Total

 

$-

 

 

$3,550

 

Potentially dilutive common share equivalents

 

 

2023

 

 

2022

 

Potentially dilutive common share equivalents

 

 

 

 

 

 

Options

 

 

1,200,000

 

 

 

-

 

Warrants

 

 

4,500,000

 

 

 

3,014,246

 

Performance Stock Units

 

 

2,700,000

 

 

 

4,000,000

 

Potentially dilutive shares outstanding

 

 

8,400,000

 

 

 

7,014,246

 

v3.23.4
PREPAID EXPENSES (Tables)
12 Months Ended
Jun. 30, 2023
PREPAID EXPENSES  
Prepaid Expenses

 

 

June 30,

2023

 

 

June 30,

2022

 

Advertising & promotion

 

$-

 

 

$5,500

 

Consultants & contractors

 

 

-

 

 

 

5,301

 

Platform costs

 

 

-

 

 

 

30,318

 

Software development

 

 

30,226

 

 

 

-

 

Total

 

$30,226

 

 

$41,119

 

v3.23.4
SOFTWARE (Tables)
12 Months Ended
Jun. 30, 2023
SOFTWARE  
Software

Balance, June 30, 2021

 

$75,750

 

Additions

 

 

335,372

 

Depreciation

 

 

-

 

Balance, June 30, 2022

 

 

411,122

 

Additions

 

 

327,645

 

Depreciation

 

 

(92,496 )

Impairment

 

 

(646,271 )

Balance, June 30, 2023

 

$-

 

v3.23.4
ACCOUNTS PAYABLE (Tables)
12 Months Ended
Jun. 30, 2023
ACCOUNTS PAYABLE  
Accounts Payable

 

 

June 30,

2023

 

 

June 30,

2022

 

Advertising & promotion

 

$45,000

 

 

$-

 

Legal & accounting

 

 

38,988

 

 

 

23,247

 

Software development

 

 

41,415

 

 

 

42,819

 

Travel

 

 

1,358

 

 

 

-

 

Accrued interest on short term debt

 

 

2,512

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total

 

$129,273

 

 

$66,066

 

v3.23.4
COMMON SHARES (Tables)
12 Months Ended
Jun. 30, 2023
COMMON SHARES  
Schedule of historical exercise data

 

 

June 30,

2023

 

Stock price

 

$0.17 - $1.10

 

Risk-free interest rate

 

3.01% - 4.21

%

Expected life

 

5 Years

 

Expected dividend rate

 

 

0

 

Expected volatility

 

192.940% - 195.25

%

Schedule of common stock purchase warrants

 

 

Number

of

Warrants

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2021

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

4,500,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

(3,014,246 )

 

 

-

 

Outstanding, June 30, 2023

 

 

4,500,000

 

 

$0.25

 

Schedule of stock purchase warrants outstanding

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted Average

Life (Years)

 

 

Expiry

Date

 

July 12, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

 

0.45

 

 

July 12, 2027

 

July 15, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.22

 

 

July 15, 2027

 

July 18, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.23

 

 

July 18, 2027

 

October 13, 2022

 

 

500,000

 

 

 

500,000

 

 

 

0.25

 

 

 

0.48

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.24

 

 

October 13, 2027

 

October 13, 2022

 

 

250,000

 

 

 

250,000

 

 

 

0.25

 

 

 

0.24

 

 

October 13, 2027

 

March 12, 2023

 

 

2,500,000

 

 

 

2,500,000

 

 

 

0.25

 

 

 

2.61

 

 

March 12, 2028

 

Total

 

 

4,500,000

 

 

 

4,500,000

 

 

 

0.25

 

 

 

4.46

 

 

 

 
Schedule of Company's outstanding non-qualified

 

 

Number of

options

 

 

Weighted Average

Exercise

Price

 

Outstanding, June 30, 2021

 

 

-

 

 $

 

 Granted

 

 

 6,000,000

 

 

 0.65

 

 Exercised

 

 

 -

 

 

-

 

 Cancelled

 

 

 -

 

 

 -

 

Outstanding, June 30, 2022

 

 

 6,000,000

 

 $

0.65

 

Granted

 

 

125,000

 

 

 0.65

 

Exercised

 

 

-

 

 

-

 

Cancelled

 

 

(125,000)

 

0.65

 

Outstanding, June 30, 2023

 

 

6,000,000

 

 $

 0.65

 
Schedule of stock options outstanding

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted Average Life (Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

25,000

 

 

0.65

 

 

8.52

 

 

January 3, 2032

 

January 4, 2022

 

 

5,750,000

 

 

 

1,150,000

 

 

0.65

 

 

8.52

 

 

January 4, 2032

 

March 1, 2023

 

 

125,000

 

 

 

25,000

 

 

0.65

 

 

8.52

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

1,200,000

 

 

0.65

 

 

8.52

 

 

 

 
Schedule of weighted average assumptions

Expected volatility

 

187.07

%

Expected option life (years)

 

6 years

 

Risk-free interest rate (10-year U.S. treasury yield)

 

4.22

%

Expected dividend yield

 

 

0%
Schedule of performance stock units

Number of Performance Units

 

 

Vesting Conditions

 

Expiry Dates

 

-

 

 

Market capitalization of the Company reaches $25 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $50 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $75 million

 

December 31, 2026

 

900,000

 

 

Market capitalization of the Company reaches $100 million

 

December 31, 2026

Schedule for the Company's outstanding performance stock units:

 

 

Number of

Performance Units

 

 

Weighted Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

(900,000)

 

 

-

 

Forfeited or cancelled

 

 

(400,000)

 

 

-

 

Outstanding, June 30, 2022

 

 

2,700,000

 

 

$-

 

Schedule for the Company's outstanding warrants:

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted

Average Life

(Years)

 

 

Expiry

Date

 

March 8, 2022

 

 

2,700,000

 

 

 

-

 

 

USD $0.00

 

 

3.51

 

 

December 31, 2026

 

Total

 

 

2,700,000

 

 

 

-

 

 

USD $0.00

 

 

3.51

 

 

 

 
Schedule of value of the award multiplying

Expected volatility

 

 

85.0%

Requisite period

 

4.00 years

 

Risk-free interest rate (US Treasury Bond rate as of the grant date)

 

 

1.80%

Expected dividend yield

 

 

0%
v3.23.4
GOING CONCERN UNCERTAINTY (Details Narrative) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
GOING CONCERN UNCERTAINTY    
Working capital $ (809,495)  
Net loss for the year (10,738,393) $ (3,147,901)
Net cash provided by used in operating activities $ (1,645,851) $ (1,618,526)
v3.23.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Consulting fees $ 0 $ 1,050
Subscription revenue 0 2,500
Total Revenue $ 0 $ 3,550
v3.23.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - shares
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Options 1,200,000  
Warrants 4,500,000 3,014,246
Performance Stock Units 2,700,000 4,000,000
Potentially dilutive shares outstanding 8,400,000 7,014,246
v3.23.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Allowance for doubtful accounts $ 0 $ 0
Initial lease term 12 years  
Impairment loss $ 646,271 $ 0
Software [Member]    
Estimated useful life 5 years  
Impairment loss $ 646,271  
v3.23.4
PREPAID EXPENSES (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
PREPAID EXPENSES    
Advertising and promotion $ 0 $ 5,500
Consultants and contractors 0 5,301
Platform costs 0 30,318
Software Development 30,226 0
Total $ 30,226 $ 41,119
v3.23.4
SOFTWARE (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
SOFTWARE    
Software, Beginning Balance $ 411,122 $ 75,750
Additions 327,645 335,372
Amortization (92,496) 0
Impairment (646,271)  
Software, Ending Balance $ 0 $ 411,122
v3.23.4
SOFTWARE (Details Narrative) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
SOFTWARE    
Impairment loss $ 646,271 $ 0
v3.23.4
ACCOUNTS PAYABLE (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
ACCOUNTS PAYABLE    
Advertising and promotion $ 45,000 $ 0
Legal & accounting 38,988 23,247
Software development 41,415 42,819
Travel 1,358 0
Accrued interest on short term debt 2,512 0
Total $ 129,273 $ 66,066
v3.23.4
RELATED PARTY TRANSACTIONS (Details Narrativess) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 01, 2023
May 25, 2023
Apr. 10, 2023
Apr. 04, 2023
Mar. 24, 2023
Mar. 23, 2023
Feb. 15, 2023
Feb. 14, 2023
Feb. 07, 2023
Feb. 06, 2023
Jan. 30, 2023
Jan. 28, 2023
Jan. 25, 2023
Jan. 24, 2023
Jan. 23, 2023
Jan. 21, 2023
Jan. 17, 2023
Jan. 16, 2023
Jan. 15, 2023
Jan. 11, 2023
Jan. 06, 2023
Dec. 05, 2022
Nov. 29, 2022
Common stock 47,343,282 25,508,044 178,572 900,000 100,000 100,000 750,000 2,000,000 250,000 1,350,000 215,000 225,000 850,000 150,000 100,000 1,000,000 430,000 1,130,000 70,000 150,000 600,000 300,000 100,000 400,000 100,000
Common stock, amount $ 47,343 $ 25,508                                              
Troy Wilkinson                                                  
Management Fees 61,998 62,500                                              
Common stock       250,000                                          
Common stock, amount       $ 0                                          
Shannon Wilkinson                                                  
Management Fees 0 101,750                                              
Common stock       250,000                                          
Net Wages 122,500 98,692                                              
Common stock, amount       $ 0                                          
Chris White                                                  
Management Fees $ 0 12,500                                              
Common stock 100,000                                                
Net Wages   74,019                                              
Gross wages $ 20,000                                                
Earl Johnson                                                  
Common stock 100,000                                                
Net Wages $ 36,000 $ 5,455                                              
Gross wages $ 10,000                                                
Michael De Valera                                                  
Common stock       100,000                                          
Common stock, amount       $ 0                                          
v3.23.4
NOTES PAYABLE (convertible only at default) (Details Narratives) - USD ($)
1 Months Ended 12 Months Ended
Apr. 12, 2023
Jan. 11, 2023
Jan. 09, 2023
Oct. 13, 2022
Jul. 15, 2022
Jul. 13, 2022
Jul. 12, 2022
Jul. 18, 2022
Jun. 30, 2023
Jun. 30, 2022
Convertible debt in exchange for cash, fair value           $ 270,000        
Convertible debt in exchange for cash           300,000        
Original issue discount           $ 30,000        
Warrants issued           500,000     900,000  
Warrant exercisable           $ 0.25        
Stock issued during period, shares     45,000              
Additional paid-in capital                 $ 14,054,838 $ 4,586,049
July 12, 2022 [Member] | Convertible Debt [Member]                    
Convertible debt in exchange for cash, fair value             $ 270,000      
Convertible debt in exchange for cash             300,000      
Common stock transaction cost                 178,500  
Original issue discount             30,000      
Additional cash proceeds             $ 27,500      
Common shares issued             350,000      
Warrants issued             500,000      
Warrant exercisable             $ 0.25      
Fair value of warrant             $ 249,971      
Increased interest rate   15.00%                
Maturity date   Jul. 12, 2023                
Incremental borrowing rate             10.00%      
Aggregate warrant, share issue             500,000      
Warrant, exercise price             $ 0.25      
Aggregate additional paid-in capital             $ 102,943   73,510  
Commitment fee                 178,500  
Carrying value of note payable                 299,926 0
Aggregating common stock shares             350,000      
Net of unamortized discounts                 74  
July 15, 2022 [Member] | Convertible Debt [Member]                    
Convertible debt in exchange for cash, fair value         $ 135,000          
Convertible debt in exchange for cash         150,000          
Original issue discount         15,000          
Additional cash proceed         $ 11,250          
Common shares issued         175,000          
Common shares issued, value         $ 89,250          
Warrants issued         250,000          
Warrant exercisable         $ 0.25          
Fair value of warrant         $ 124,984          
Interest rate         10.00%          
Increased interest rate   15.00%                
Maturity date   Jul. 12, 2023                
Incremental borrowing rate         10.00%          
Aggregate warrant, share issued         250,000          
Warrant, exercise price         $ 0.25          
Aggregate additional paid-in capital         $ 51,471          
Commitment fee         $ 89,250          
Carrying value of note payable                 149,963 $ 0
Stock issued during period, shares         175,000          
Additional paid-in capital         $ 36,755          
Net of unamortized discounts                 37  
July 18, 2022 [Member] | Convertible Debt [Member]                    
Convertible debt in exchange for cash, fair value               $ 135,000    
Convertible debt in exchange for cash               150,000    
Original issue discount               15,000    
Additional cash proceeds               $ 11,250    
Common shares issued               175,000    
Common shares issued, value               $ 89,250    
Warrants issued               250,000    
Warrant exercisable               $ 0.25    
Fair value of warrant               $ 124,994    
Interest rate               10.00%    
Increased interest rate   15.00%                
Maturity date   Jul. 12, 2023                
Incremental borrowing rate               10.00%    
Aggregate warrant, share issued               250,000    
Warrant, exercise price               $ 0.25    
Aggregate additional paid-in capital               $ 51,474    
Commitment fee               $ 89,250    
Stock issued during period, shares               175,000    
Additional paid-in capital               $ 36,755    
Note Payable                 149,962  
Net of unamortized discounts                 38  
October 13, 2022 [Member] | Convertible Debt [Member]                    
Convertible debt in exchange for cash, fair value       $ 135,000            
Convertible debt in exchange for cash       150,000            
Original issue discount       15,000            
Additional cash proceeds       $ 23,750            
Common shares issued       416,667            
Common shares issued, value       $ 187,625            
Warrants issued       500,000            
Warrant exercisable       $ 0.25            
Fair value of warrant       $ 220,526            
Interest rate       10.00%            
Increased interest rate 15.00%                  
Maturity date Oct. 13, 2023     Apr. 13, 2023            
Incremental borrowing rate       15.00%            
Aggregate warrant, share issued       500,000            
Warrant, exercise price       $ 0.25            
Aggregate additional paid-in capital       $ 59,265            
Commitment fee       $ 187,625            
Stock issued during period, shares       416,667            
Additional paid-in capital       $ 50,423            
Note Payable                 145,923  
Net of unamortized discounts                 4,077  
October 13, 2022 [Member] | Convertible Debt One [Member]                    
Convertible debt in exchange for cash, fair value       67,500            
Convertible debt in exchange for cash       75,000            
Original issue discount       7,500            
Additional cash proceeds       $ 5,625            
Common shares issued       208,333            
Common shares issued, value       $ 93,812            
Warrants issued       250,000            
Warrant exercisable       $ 0.25            
Interest rate       10.00%            
Increased interest rate 15.00%                  
Maturity date Oct. 13, 2023     Apr. 13, 2023            
Incremental borrowing rate       10.00%            
Aggregate warrant, share issued       250,000            
Warrant, exercise price       $ 0.25            
Aggregate additional paid-in capital       $ 29,633            
Commitment fee       $ 93,812            
Stock issued during period, shares       208,333            
Additional paid-in capital       $ 25,212            
Note Payable                 72,960  
Net of unamortized discounts                 2,040  
October 13, 2022 [Member] | Convertible Debt Two [Member]                    
Convertible debt in exchange for cash, fair value       67,500            
Convertible debt in exchange for cash       75,000            
Original issue discount       7,500            
Additional cash proceeds       $ 5,625            
Common shares issued       208,333            
Common shares issued, value       $ 93,812            
Warrants issued       250,000            
Warrant exercisable       $ 0.25            
Fair value of warrant       $ 110,263            
Interest rate       10.00%            
Increased interest rate 15.00%                  
Maturity date Oct. 13, 2023     Apr. 13, 2023            
Incremental borrowing rate       10.00%            
Aggregate warrant, share issued       250,000            
Warrant, exercise price       $ 0.25            
Aggregate additional paid-in capital       $ 29,633            
Commitment fee       $ 93,812            
Stock issued during period, shares       208,333            
Additional paid-in capital       $ 25,212            
Note Payable                 72,960  
Net of unamortized discounts                 $ 2,040  
v3.23.4
COMMON SHARES (Details)
12 Months Ended
Jun. 30, 2023
$ / shares
Expected dividend rate 0.00%
Minimum [Member]  
Stock price $ 0.17
Risk-free interest rate 3.01%
Expected volatility 192.94%
Maximum [Member]  
Stock price $ 1.10
Risk-free interest rate 4.21%
Expected life 5 years
Expected volatility 195.25%
v3.23.4
COMMON SHARES (Details 1) - $ / shares
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
COMMON SHARES    
Number Of Warrants Outstanding, Beginning 3,014,246 3,014,246
Number Of Warrants Issued 4,500,000 0
Number Of Warrants Expired (3,014,246) 0
Number Of Warrants Outstanding,Ending Balance 4,500,000 3,014,246
Weighted Average Exercise Price Outstanding, Beginning $ 0.25 $ 0.25
Weighted Average Exercise Price Issued 0.25 0
Weighted Average Exercise Price Exercised 0 0
Weighted Average Exercise Price Expired 0 0.65
Weighted Average Exercise Price Outstanding, ending $ 0.25 $ 0.25
v3.23.4
COMMON SHARES (Details 2)
12 Months Ended
Jun. 30, 2023
$ / shares
shares
Weighted Average life 4 years 5 months 15 days
Number of Warrants outstanding 4,500,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 4,500,000
July 12, 2022 [Member]  
Weighted Average life 5 months 12 days
Number of Warrants outstanding 500,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 500,000
Expiry Date July 12, 2027
July 15, 2022 [Member]  
Weighted Average life 2 months 19 days
Number of Warrants outstanding 250,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 250,000
Expiry Date July 15, 2027
July 18, 2022 [Member]  
Weighted Average life 2 months 23 days
Number of Warrants outstanding 250,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 250,000
Expiry Date July 18, 2027
October 13, 2022, One[Member]  
Weighted Average life 5 months 23 days
Number of Warrants outstanding 500,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 500,000
Expiry Date October 13, 2027
October 13, 2022, Two[Member]  
Weighted Average life 2 months 26 days
Number of Warrants outstanding 250,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 250,000
Expiry Date October 13, 2027
October 13, 2022, Three[Member]  
Weighted Average life 2 months 26 days
Number of Warrants outstanding 250,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 250,000
Expiry Date October 13, 2027
March 12, 2023, [Member]  
Weighted Average life 2 years 7 months 9 days
Number of Warrants outstanding 2,500,000
Exercise | $ / shares $ 0.25
Number of Warrants Exercisable 2,500,000
Expiry Date March 12, 2028
v3.23.4
COMMON SHARES (Details 3) - $ / shares
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
COMMON SHARES    
Number Of Warrants Outstanding, Beginning 6,000,000 0
Number Of Warrants Outstanding, Granted 125,000 6,000,000
Number Of Warrants Outstanding, Cancelled 125,000 0
Number Of Warrants Outstanding, Ending Balance 6,000,000 6,000,000
Weighted Average Exercise Price Outstanding, Beginning Balance $ 0.65 $ 0
Weighted Average Exercise Price Exercised 0 0
Weighted Average Exercise Price Granted 0.65 0.65
Weighted Average Exercise Price Cancelled 0 0.65
Weighted Average Exercise Price Outstanding, Ending Balance $ 0.65 $ 0.65
v3.23.4
COMMON SHARES (Details 4)
12 Months Ended
Jun. 30, 2023
$ / shares
shares
Number of option outstanding 6,000,000
Exercise | $ / shares $ 0.65
Weighted Average life 8 years 6 months 7 days
Number of option Exercisable 1,200,000
January 3, 2022 [Member]  
Number of option outstanding 125,000
Exercise | $ / shares $ 0.65
Weighted Average life 8 years 6 months 7 days
Number of option Exercisable 25,000
Expiry Date January 3, 2032
January 4, 2022 [Member]  
Number of option outstanding 5,750,000
Exercise | $ / shares $ 0.65
Weighted Average life 8 years 6 months 7 days
Number of option Exercisable 1,150,000
Expiry Date January 4, 2032
March 1, 2023 [Member]  
Number of option outstanding 125,000
Exercise | $ / shares $ 0.65
Weighted Average life 8 years 6 months 7 days
Number of option Exercisable 25,000
Expiry Date January 4, 2032
v3.23.4
COMMON SHARES (Details 5)
12 Months Ended
Jun. 30, 2023
COMMON SHARES  
Expected volatility 187.07%
Expected option life (years) 6 years
Risk-free interest rate (10-year U.S. treasury yield) 4.22%
Expected dividend yield 0.00%
v3.23.4
COMMON SHARES (Details 6) - directors, officers and certain key consultants
12 Months Ended
Jun. 30, 2023
shares
Performance Stock Units  
Number of Performance Units 0
Vesting Conditions of Performance Units Market capitalization of the Company reaches $25 million
Expiry Dates Performance Stock Units December 31, 2026
Performance Stock Units 1  
Number of Performance Units 900,000
Vesting Conditions of Performance Units Market capitalization of the Company reaches $50 million
Expiry Dates Performance Stock Units December 31, 2026
Performance Stock Units 2  
Number of Performance Units 900,000
Vesting Conditions of Performance Units Market capitalization of the Company reaches $75 million
Expiry Dates Performance Stock Units December 31, 2026
Performance Stock Units 3  
Number of Performance Units 900,000
Vesting Conditions of Performance Units Market capitalization of the Company reaches $100 million
Expiry Dates Performance Stock Units December 31, 2026
v3.23.4
COMMON SHARES (Details 7) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
COMMON SHARES    
Number of Warrants Outstanding, beginning 4,000,000  
Number of Warrants Granted $ 0  
Number of Warrants Exercised (900,000)  
Number of Warrants Forfeited or cancelled $ 400,000  
Number of Warrants Outstanding,Ending 2,700,000  
Weighted Average Exercise Price Beginning balance $ 0  
Weighted Average Exercise Price Granted 0  
Weighted Average Exercise Price Released 0 $ 0
Weighted Average Exercise Price Forfeited or Cancelled 0 $ 0.65
Weighted Average Exercise Price Ending, Balance $ 0  
v3.23.4
COMMON SHARES (Details 8)
12 Months Ended
Jun. 30, 2023
$ / shares
shares
Number of option outstanding 2,700,000
Number exercisable 0
Exercise | $ / shares $ 0.00
Weighted average life (Years) 3 years 6 months 3 days
March 8, 2022 [Member]  
Number of option outstanding 2,700,000
Number exercisable 0
Exercise | $ / shares $ 0.00
Weighted average life (Years) 3 years 6 months 3 days
Expiry date December 31, 2026
v3.23.4
COMMON SHARES (Details 9)
12 Months Ended
Jun. 30, 2023
COMMON SHARES  
Expected volatility 85.00%
Expected life 4 years
Risk-free interest rate 1.80%
Expected dividend rate 0.00%
v3.23.4
COMMON SHARES (Details Narrative) - USD ($)
1 Months Ended 4 Months Ended 12 Months Ended
Mar. 12, 2023
Feb. 07, 2023
Feb. 06, 2023
Jan. 15, 2023
Jan. 11, 2023
Jan. 09, 2023
Jan. 06, 2023
Dec. 05, 2022
Oct. 13, 2022
Jul. 15, 2022
Jul. 13, 2022
Jul. 12, 2022
Apr. 28, 2021
Apr. 22, 2021
Mar. 25, 2021
Mar. 24, 2023
Feb. 15, 2023
Feb. 14, 2023
Jan. 30, 2023
Jan. 28, 2023
Jan. 25, 2023
Jan. 24, 2023
Jan. 23, 2023
Jan. 21, 2023
Jan. 17, 2023
Jan. 16, 2023
Nov. 29, 2022
Jul. 18, 2022
Oct. 28, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 01, 2023
May 25, 2023
Apr. 10, 2023
Apr. 04, 2023
Mar. 23, 2023
Mar. 20, 2023
Convertible debt in exchange for cash, fair value                     $ 270,000                                                    
Common stock, authorized                                                           100,000,000 100,000,000           400,000
Market capitalization                                                           $ 25,000,000              
Share-based compensation                                                           $ 1,993,585 $ 905,962            
Common stock, par value   $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.20 $ 0.10 $ 0.10               $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10     $ 0.001 $ 0.001 $ 0.65   $ 0.85 $ 1.04 $ 0.78  
Convertible debt in exchange for cash                     300,000                                                    
Non-related party , Shares 2,233,333                                                                        
Share price $ 0.75                                                                        
Original issue discount                     $ 30,000                                                    
Conversion price                                                             $ 0.10            
Total value   $ 21,500 $ 22,500 $ 60,000 $ 30,000   $ 10,000 $ 40,000               $ 75,000 $ 25,000 $ 135,000 $ 85,000 $ 15,000 $ 10,000 $ 100,000 $ 43,000 $ 113,000 $ 7,000 $ 15,000 $ 10,000       $ 35,321            
Stock issued           45,000                                                              
Stock issued for services           500,000                                                              
Weighted average remaining contractual life of warrants outstanding                                                           4 years 5 months 15 days              
Warrants intrinsic value                                                           $ 0              
Common stock, issued   215,000 225,000 600,000 300,000   100,000 400,000               750,000 250,000 1,350,000 850,000 150,000 100,000 1,000,000 430,000 1,130,000 70,000 150,000 100,000     47,343,282 25,508,044 178,572 900,000 100,000 100,000 2,000,000  
Warrants issued                     500,000                                     900,000              
Warrant exercisable                     $ 0.25                                                    
Number of warrants granted 2,500,000               250,000                                         900,000              
Additional paid in capital                                                           $ 14,054,838 $ 4,586,049            
Weighted average exercise price granted $ 0.25                                                                        
Number of Warrants Outstanding                                                             4,000,000            
Aggregate warrant, exercise price                     $ 0.25                                                    
Non qualified stock option [member]                                                                          
Share-based compensation                                                           1,070,990              
Warrant [Member]                                                                          
Number of warrants granted                 500,000 250,000     307,408 506,838 1,100,000                         250,000                  
Additional paid in capital                 $ 59,265 $ 51,471   $ 102,943                               $ 51,474                  
Weighted average exercise price granted                 $ 0.25 $ 0.25   $ 0.25 $ 0.25 $ 0.25 $ 0.25                         $ 0.25                  
Fair value of warrant granted                 $ 220,526 $ 124,984   $ 249,971 $ 196,399 $ 399,087 $ 148,438                         $ 124,994                  
Warrant One [Member]                                                                          
Number of warrants granted 2,500,000               250,000                                                        
Additional paid in capital                 $ 29,633                                                        
Weighted average exercise price granted $ 0.25               $ 0.25                                                        
Fair value of warrant granted                 $ 110,263                                                        
Warrant Two [Member]                                                                          
Additional paid in capital                 29,633                                                        
Fair value of warrant granted                 110,263                                                        
Warrant Three [Member]                                                                          
Fair value of warrant granted                 $ 1,847,450                                                        
share-based compensation Member                                                                          
Share-based compensation                                                           475,453              
Outstanding performance units                                                           775,301              
Remaining Share based compensation                                                           $ 124,699              
Common Shares [Member]                                                                          
Total value                                                         $ 1,425,202                
Stock issued                                                         5,558,810                
July 12, 2022                                                                          
Share price                                                           $ 0.21              
Common stock, issued                                                           350,000              
July 15, 2022                                                                          
Share price                                                           $ 0.21              
Common stock, issued                                                           175,000              
July 18, 2022                                                                          
Share price                                                           $ 0.21              
Common stock, issued                                                           175,000              
July 26, 2022                                                                          
Share price                                                           $ 0.51              
Common stock, issued                                                           275,000              
Marketing Services                                                           $ 140,250              
October 13, One 2022                                                                          
Share price                                                           $ 0.12              
Common stock, issued                                                           208,333              
October 13, Two 2022                                                                          
Share price                                                           $ 0.12              
Common stock, issued                                                           208,333              
October 15, 2021                                                                          
Share price                                                             $ 0.80            
Common stock, issued                                                             125,000            
Marketing Services                                                             $ 100,000            
October 28, 2021                                                                          
Share price                                                             $ 0.70            
Common stock, issued                                                             28,572            
Legal services                                                             $ 20,000            
December 8, 2021                                                                          
Share price                                                             $ 0.71            
Common stock, issued                                                             50,000            
Consulting services                                                             $ 35,250            
March 25, 2022                                                                          
Share price                                                             $ 0.60            
Common stock, issued                                                             12,000            
Legal services                                                             $ 7,200            
December 31, 2021                                                                          
Total value                                                             $ 58,394            
Common stock, issued                                                             583,936            
January 1, 2022                                                                          
Conversion price                                                             $ 0.65            
Total value                                                             $ 65,000            
Common stock, issued                                                             100,000            
February 6, 2023 [Member]                                                                          
Common stock, par value     $ 0.18                                                                    
Common stock, issued     1,000,000                                                                    
May 19, 2022                                                                          
Share price                                                             $ 0.577            
Common stock, issued                                                             400,000            
Marketing Services                                                             $ 230,800            
October 12, 2022                                                                          
Share price                                                           $ 0.12              
Common stock, issued                                                           416,667              
May 24, One 2023                                                                          
Share price                                                           $ 0.10              
Total value                                                           $ 393,000              
Common stock, issued                                                           3,930,000              
May 24, Two 2023                                                                          
Share price                                                           $ 0.10              
Total value                                                           $ 17,000              
Common stock, issued                                                           170,000              
June 16, 2023                                                                          
Share price                                                           $ 0.10              
Total value                                                           $ 70,000              
Common stock, issued                                                           700,000              
v3.23.4
INCOME TAXES (Details Narrative) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
INCOME TAXES    
Net operating loss carry forward $ 6,818,462 $ 2,909,935
v3.23.4
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 15, 2023
Jul. 03, 2023
Aug. 22, 2023
Aug. 17, 2023
Jul. 27, 2023
Jun. 30, 2023
Jun. 30, 2022
Oct. 06, 2023
Sep. 19, 2023
Sep. 15, 2023
Sep. 01, 2023
Aug. 21, 2023
Jun. 01, 2023
May 25, 2023
Apr. 10, 2023
Apr. 04, 2023
Mar. 24, 2023
Mar. 23, 2023
Feb. 15, 2023
Feb. 14, 2023
Feb. 07, 2023
Feb. 06, 2023
Jan. 30, 2023
Jan. 28, 2023
Jan. 25, 2023
Jan. 24, 2023
Jan. 23, 2023
Jan. 21, 2023
Jan. 17, 2023
Jan. 16, 2023
Jan. 15, 2023
Jan. 11, 2023
Jan. 09, 2023
Jan. 06, 2023
Dec. 05, 2022
Nov. 29, 2022
Number of warrants outstanding, granted           125,000 6,000,000                                                          
Exercise           $ 0.00                                                            
Weighted average exercise price issued           0.25 $ 0                                                          
Common stock, par value           $ 0.001 $ 0.001           $ 0.65   $ 0.85 $ 1.04 $ 0.10 $ 0.78 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.20 $ 0.10 $ 0.10 $ 0.10
Weighted Average life           8 years 6 months 7 days                                                            
Common stock, issued           47,343,282 25,508,044           178,572 900,000 100,000 100,000 750,000 2,000,000 250,000 1,350,000 215,000 225,000 850,000 150,000 100,000 1,000,000 430,000 1,130,000 70,000 150,000 600,000 300,000   100,000 400,000 100,000
Subsequent Event [Member]                                                                        
Number of warrants outstanding, granted   1,250,000                                                                    
Common stock, total value     $ 90,000 $ 10,000 $ 50,000                                                              
Interest amount $ 15,000                                                                      
Principal amount $ 15,000                                                                      
Common stock, par value   $ 0.48 $ 0.15 $ 0.10 $ 0.10     $ 0.10 $ 0.22 $ 0.2328   $ 0.10                                                
Common stock, issued   250,000 600,000 100,000 500,000       500,000 250,000 50,000 800,000                                                
Subsequent Event [Member] | July 3, 2023 [Member]                                                                        
Exercise   $ 0.25                                                                    
Warrant price   $ 710,118                                                                    
Common stock, par value   $ 0.10                                                                    
Number of warrant granted   1,250,000                                                                    
Common stock, issued   1,116,667                                                                    
Subsequent Event [Member] | Director officers and key consultants [Member]                                                                        
Common stock, par value   $ 0.65               $ 0.2328                                                    
Common stock, issued   100,000           1,000,000   100,000                                                    
Subsequent Event [Member] | Black Scholes Option Pricing Model [Member]                                                                        
Exercise   $ 0.10                                                                    
Warrant price   $ 710,118                                                                    
Weighted average exercise price issued   $ 0.25                                                                    
Common stock, par value   $ 1,116,667                                                                    
Weighted Average life   5 years                                                                    

1 Year Tego Cyber (PK) Chart

1 Year Tego Cyber (PK) Chart

1 Month Tego Cyber (PK) Chart

1 Month Tego Cyber (PK) Chart

Your Recent History

Delayed Upgrade Clock